Financial Metrics

RJF RAYMOND JAMES FINANCIAL INC

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1341110000.0	—	USD	10-Q	2017-05-10
Quarterly	2016-06-30	1386997000.0	+3.4%	USD	10-Q	2017-08-08
Quarterly	2016-12-31	1528768000.0	+10.2%	USD	10-Q	2018-02-08
Quarterly	2017-03-31	1600314000.0	+4.7%	USD	10-Q	2018-05-09
Quarterly	2017-06-30	1663107000.0	+3.9%	USD	10-Q	2018-08-07
Quarterly	2017-12-31	1766000000.0	+6.2%	USD	10-Q	2019-02-08
Quarterly	2018-03-31	1857000000.0	+5.2%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	1891000000.0	+1.8%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	2004000000.0	+6.0%	USD	10-Q	2020-02-07
Quarterly	2019-03-31	1934000000.0	-3.5%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	2000000000.0	+3.4%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	2060000000.0	+3.0%	USD	10-Q	2021-02-08
Quarterly	2020-03-31	2111000000.0	+2.5%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	1876000000.0	-11.1%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	2260000000.0	+20.5%	USD	10-Q	2022-02-08
Quarterly	2021-03-31	2409000000.0	+6.6%	USD	10-Q	2022-05-09
Quarterly	2021-06-30	2511000000.0	+4.2%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	2818000000.0	+12.2%	USD	10-Q	2023-02-03
Quarterly	2022-03-31	2711000000.0	-3.8%	USD	10-Q	2023-05-08
Quarterly	2022-06-30	2778000000.0	+2.5%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	3027000000.0	+9.0%	USD	10-Q	2024-02-07
Quarterly	2023-03-31	3157000000.0	+4.3%	USD	10-Q	2024-05-07
Quarterly	2023-06-30	3293000000.0	+4.3%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	3520000000.0	+6.9%	USD	10-Q	2025-02-07
Quarterly	2024-03-31	3638000000.0	+3.4%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	3762000000.0	+3.4%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	4035000000.0	+7.3%	USD	10-Q	2026-02-06
Quarterly	2025-03-31	3845000000.0	-4.7%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	3842000000.0	-0.1%	USD	10-Q	2025-08-06
Quarterly	2025-12-31	4176000000.0	+8.7%	USD	10-Q	2026-02-06
Annual	2016-09-30	5521120000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	6525000000.0	+18.2%	USD	10-K	2019-11-26
Annual	2018-09-30	7476000000.0	+14.6%	USD	10-K	2020-11-24
Annual	2019-09-30	8023000000.0	+7.3%	USD	10-K	2021-11-23
Annual	2020-09-30	8168000000.0	+1.8%	USD	10-K	2022-11-22
Annual	2021-09-30	9910000000.0	+21.3%	USD	10-K	2023-11-21
Annual	2022-09-30	11308000000.0	+14.1%	USD	10-K	2024-11-26
Annual	2023-09-30	12992000000.0	+14.9%	USD	10-K	2025-11-25
Annual	2024-09-30	14923000000.0	+14.9%	USD	10-K	2025-11-25
Annual	2025-09-30	15912000000.0	+6.6%	USD	10-K	2025-11-25

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Operating Income

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	121837000.0	—	USD	10-Q	2017-05-10
Quarterly	2016-06-30	132593000.0	+8.8%	USD	10-Q	2017-08-08
Quarterly	2016-12-31	147703000.0	+11.4%	USD	10-Q	2018-02-08
Quarterly	2017-03-31	108545000.0	-26.5%	USD	10-Q	2018-05-09
Quarterly	2017-06-30	185351000.0	+70.8%	USD	10-Q	2018-08-07
Quarterly	2017-12-31	119000000.0	-35.8%	USD	10-Q	2019-02-08
Quarterly	2018-03-31	243000000.0	+104.2%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	232000000.0	-4.5%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	249000000.0	+7.3%	USD	10-Q	2020-02-07
Quarterly	2019-03-31	261000000.0	+4.8%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	259000000.0	-0.8%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	268000000.0	+3.5%	USD	10-Q	2021-02-08
Quarterly	2020-03-31	169000000.0	-36.9%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	172000000.0	+1.8%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	312000000.0	+81.4%	USD	10-Q	2022-02-08
Quarterly	2021-03-31	355000000.0	+13.8%	USD	10-Q	2022-05-09
Quarterly	2021-06-30	307000000.0	-13.5%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	446000000.0	+45.3%	USD	10-Q	2023-02-03
Quarterly	2022-03-31	323000000.0	-27.6%	USD	10-Q	2023-05-08
Quarterly	2022-06-30	301000000.0	-6.8%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	509000000.0	+69.1%	USD	10-Q	2024-02-07
Quarterly	2023-03-31	427000000.0	-16.1%	USD	10-Q	2024-05-07
Quarterly	2023-06-30	369000000.0	-13.6%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	498000000.0	+35.0%	USD	10-Q	2025-02-07
Quarterly	2024-03-31	476000000.0	-4.4%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	492000000.0	+3.4%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	600000000.0	+22.0%	USD	10-Q	2026-02-06
Quarterly	2025-03-31	495000000.0	-17.5%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	436000000.0	-11.9%	USD	10-Q	2025-08-06
Quarterly	2025-12-31	563000000.0	+29.1%	USD	10-Q	2026-02-06
Annual	2016-09-30	540651000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	636000000.0	+17.6%	USD	10-K	2019-11-26
Annual	2018-09-30	857000000.0	+34.7%	USD	10-K	2020-11-24
Annual	2019-09-30	1034000000.0	+20.7%	USD	10-K	2021-11-23
Annual	2020-09-30	818000000.0	-20.9%	USD	10-K	2022-11-22
Annual	2021-09-30	1403000000.0	+71.5%	USD	10-K	2023-11-21
Annual	2022-09-30	1509000000.0	+7.6%	USD	10-K	2024-11-26
Annual	2023-09-30	1739000000.0	+15.2%	USD	10-K	2025-11-25
Annual	2024-09-30	2068000000.0	+18.9%	USD	10-K	2025-11-25
Annual	2025-09-30	2135000000.0	+3.2%	USD	10-K	2025-11-25

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.89	—	USD/shares	10-Q	2017-05-10
Quarterly	2016-06-30	0.89	+0.0%	USD/shares	10-Q	2017-08-08
Quarterly	2016-12-31	1.03	+15.7%	USD/shares	10-Q	2018-02-08
Quarterly	2017-03-31	0.78	-24.3%	USD/shares	10-Q	2018-05-09
Quarterly	2017-06-30	1.27	+62.8%	USD/shares	10-Q	2018-08-07
Quarterly	2017-12-31	0.82	-35.4%	USD/shares	10-Q	2019-02-08
Quarterly	2018-03-31	1.67	+103.7%	USD/shares	10-Q	2019-05-09
Quarterly	2018-06-30	1.59	-4.8%	USD/shares	10-Q	2019-08-08
Quarterly	2018-12-31	1.73	+8.8%	USD/shares	10-Q	2020-02-07
Quarterly	2019-03-31	1.85	+6.9%	USD/shares	10-Q	2020-05-08
Quarterly	2019-06-30	1.84	-0.5%	USD/shares	10-Q	2020-08-07
Quarterly	2019-12-31	1.93	+4.9%	USD/shares	10-Q	2021-02-08
Quarterly	2020-03-31	1.22	-36.8%	USD/shares	10-Q	2021-05-07
Quarterly	2020-06-30	1.25	+2.5%	USD/shares	10-Q	2021-08-09
Quarterly	2020-12-31	1.52	+21.6%	USD/shares	10-Q	2022-02-08
Quarterly	2021-03-31	1.72	+13.2%	USD/shares	10-Q	2022-05-09
Quarterly	2021-06-30	1.49	-13.4%	USD/shares	10-Q	2022-08-08
Quarterly	2021-12-31	2.16	+45.0%	USD/shares	10-Q	2023-02-03
Quarterly	2022-03-31	1.56	-27.8%	USD/shares	10-Q	2023-05-08
Quarterly	2022-06-30	1.41	-9.6%	USD/shares	10-Q	2023-08-04
Quarterly	2022-12-31	2.36	+67.4%	USD/shares	10-Q	2024-02-07
Quarterly	2023-03-31	1.97	-16.5%	USD/shares	10-Q	2024-05-07
Quarterly	2023-06-30	1.75	-11.2%	USD/shares	10-Q	2024-08-06
Quarterly	2023-12-31	2.38	+36.0%	USD/shares	10-Q	2025-02-07
Quarterly	2024-03-31	2.27	-4.6%	USD/shares	10-Q	2025-05-07
Quarterly	2024-06-30	2.37	+4.4%	USD/shares	10-Q	2025-08-06
Quarterly	2024-12-31	2.94	+24.1%	USD/shares	10-Q	2026-02-06
Quarterly	2025-03-31	2.41	-18.0%	USD/shares	10-Q	2025-05-07
Quarterly	2025-06-30	2.16	-10.4%	USD/shares	10-Q	2025-08-06
Quarterly	2025-12-31	2.85	+31.9%	USD/shares	10-Q	2026-02-06
Annual	2016-09-30	3.72	—	USD/shares	10-K	2018-11-21
Annual	2017-09-30	4.43	+19.1%	USD/shares	10-K	2019-11-26
Annual	2018-09-30	5.89	+33.0%	USD/shares	10-K	2020-11-24
Annual	2019-09-30	4.88	-17.1%	USD/shares	10-K	2021-11-23
Annual	2020-09-30	3.96	-18.9%	USD/shares	10-K	2022-11-22
Annual	2021-09-30	6.81	+72.0%	USD/shares	10-K	2023-11-21
Annual	2022-09-30	7.16	+5.1%	USD/shares	10-K	2024-11-26
Annual	2023-09-30	8.16	+14.0%	USD/shares	10-K	2025-11-25
Annual	2024-09-30	9.94	+21.8%	USD/shares	10-K	2025-11-25
Annual	2025-09-30	10.53	+5.9%	USD/shares	10-K	2025-11-25

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.87	—	USD/shares	10-Q	2017-05-10
Quarterly	2016-06-30	0.87	+0.0%	USD/shares	10-Q	2017-08-08
Quarterly	2016-12-31	1.0	+14.9%	USD/shares	10-Q	2018-02-08
Quarterly	2017-03-31	0.77	-23.0%	USD/shares	10-Q	2018-05-09
Quarterly	2017-06-30	1.24	+61.0%	USD/shares	10-Q	2018-08-07
Quarterly	2017-12-31	0.8	-35.5%	USD/shares	10-Q	2019-02-08
Quarterly	2018-03-31	1.63	+103.7%	USD/shares	10-Q	2019-05-09
Quarterly	2018-06-30	1.55	-4.9%	USD/shares	10-Q	2019-08-08
Quarterly	2018-12-31	1.69	+9.0%	USD/shares	10-Q	2020-02-07
Quarterly	2019-03-31	1.81	+7.1%	USD/shares	10-Q	2020-05-08
Quarterly	2019-06-30	1.8	-0.6%	USD/shares	10-Q	2020-08-07
Quarterly	2019-12-31	1.89	+5.0%	USD/shares	10-Q	2021-02-08
Quarterly	2020-03-31	1.2	-36.5%	USD/shares	10-Q	2021-05-07
Quarterly	2020-06-30	1.23	+2.5%	USD/shares	10-Q	2021-08-09
Quarterly	2020-12-31	1.48	+20.3%	USD/shares	10-Q	2022-02-08
Quarterly	2021-03-31	1.68	+13.5%	USD/shares	10-Q	2022-05-09
Quarterly	2021-06-30	1.45	-13.7%	USD/shares	10-Q	2022-08-08
Quarterly	2021-12-31	2.1	+44.8%	USD/shares	10-Q	2023-02-03
Quarterly	2022-03-31	1.52	-27.6%	USD/shares	10-Q	2023-05-08
Quarterly	2022-06-30	1.38	-9.2%	USD/shares	10-Q	2023-08-04
Quarterly	2022-12-31	2.3	+66.7%	USD/shares	10-Q	2024-02-07
Quarterly	2023-03-31	1.93	-16.1%	USD/shares	10-Q	2024-05-07
Quarterly	2023-06-30	1.71	-11.4%	USD/shares	10-Q	2024-08-06
Quarterly	2023-12-31	2.32	+35.7%	USD/shares	10-Q	2025-02-07
Quarterly	2024-03-31	2.22	-4.3%	USD/shares	10-Q	2025-05-07
Quarterly	2024-06-30	2.31	+4.1%	USD/shares	10-Q	2025-08-06
Quarterly	2024-12-31	2.86	+23.8%	USD/shares	10-Q	2026-02-06
Quarterly	2025-03-31	2.36	-17.5%	USD/shares	10-Q	2025-05-07
Quarterly	2025-06-30	2.12	-10.2%	USD/shares	10-Q	2025-08-06
Quarterly	2025-12-31	2.79	+31.6%	USD/shares	10-Q	2026-02-06
Annual	2016-09-30	3.65	—	USD/shares	10-K	2018-11-21
Annual	2017-09-30	4.33	+18.6%	USD/shares	10-K	2019-11-26
Annual	2018-09-30	5.75	+32.8%	USD/shares	10-K	2020-11-24
Annual	2019-09-30	4.78	-16.9%	USD/shares	10-K	2021-11-23
Annual	2020-09-30	3.88	-18.8%	USD/shares	10-K	2022-11-22
Annual	2021-09-30	6.63	+70.9%	USD/shares	10-K	2023-11-21
Annual	2022-09-30	6.98	+5.3%	USD/shares	10-K	2024-11-26
Annual	2023-09-30	7.97	+14.2%	USD/shares	10-K	2025-11-25
Annual	2024-09-30	9.7	+21.7%	USD/shares	10-K	2025-11-25
Annual	2025-09-30	10.3	+6.2%	USD/shares	10-K	2025-11-25

Balance Sheet

Metrics: 9

Cash and Equivalents

Q: 40 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1479786000.0	—	USD	10-Q	2017-05-10
Quarterly	2016-06-30	1978057000.0	+33.7%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	1650452000.0	-16.6%	USD	10-Q	2018-08-07
Quarterly	2016-12-31	2528275000.0	+53.2%	USD	10-Q	2018-02-08
Quarterly	2017-03-31	2636326000.0	+4.3%	USD	10-Q	2018-05-09
Quarterly	2017-06-30	2615479000.0	-0.8%	USD	10-Q	2018-08-07
Quarterly	2017-09-30	3669672000.0	+40.3%	USD	10-Q	2018-08-07
Quarterly	2017-12-31	3898000000.0	+6.2%	USD	10-Q	2019-02-08
Quarterly	2018-03-31	3140000000.0	-19.4%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	3180000000.0	+1.3%	USD	10-Q	2019-08-08
Quarterly	2018-09-30	3500000000.0	+10.1%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	4322000000.0	+23.5%	USD	10-Q	2020-02-07
Quarterly	2019-03-31	3831000000.0	-11.4%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	3596000000.0	-6.1%	USD	10-Q	2020-08-07
Quarterly	2019-09-30	3957000000.0	+10.0%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	4109000000.0	+3.8%	USD	10-Q	2021-02-08
Quarterly	2020-03-31	10648000000.0	+159.1%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	5632000000.0	-47.1%	USD	10-Q	2021-08-09
Quarterly	2020-09-30	5390000000.0	-4.3%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	5377000000.0	-0.2%	USD	10-Q	2022-02-08
Quarterly	2021-03-31	5851000000.0	+8.8%	USD	10-Q	2022-05-09
Quarterly	2021-06-30	5982000000.0	+2.2%	USD	10-Q	2022-08-08
Quarterly	2021-09-30	7201000000.0	+20.4%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	8216000000.0	+14.1%	USD	10-Q	2023-02-03
Quarterly	2022-03-31	5715000000.0	-30.4%	USD	10-Q	2023-05-08
Quarterly	2022-06-30	5958000000.0	+4.3%	USD	10-Q	2023-08-04
Quarterly	2022-09-30	6178000000.0	+3.7%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	6177000000.0	-0.0%	USD	10-Q	2024-02-07
Quarterly	2023-03-31	8663000000.0	+40.2%	USD	10-Q	2024-05-07
Quarterly	2023-06-30	8375000000.0	-3.3%	USD	10-Q	2024-08-06
Quarterly	2023-09-30	9313000000.0	+11.2%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	10206000000.0	+9.6%	USD	10-Q	2025-02-07
Quarterly	2024-03-31	10001000000.0	-2.0%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	9095000000.0	-9.1%	USD	10-Q	2025-08-06
Quarterly	2024-09-30	10998000000.0	+20.9%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	10048000000.0	-8.6%	USD	10-Q	2026-02-06
Quarterly	2025-03-31	9662000000.0	-3.8%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	9195000000.0	-4.8%	USD	10-Q	2025-08-06
Quarterly	2025-09-30	11389000000.0	+23.9%	USD	10-Q	2026-02-06
Quarterly	2025-12-31	9890000000.0	-13.2%	USD	10-Q	2026-02-06
Annual	2016-09-30	1650452000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	3670000000.0	+122.4%	USD	10-K	2019-11-26
Annual	2018-09-30	3500000000.0	-4.6%	USD	10-K	2020-11-24
Annual	2019-09-30	3957000000.0	+13.1%	USD	10-K	2021-11-23
Annual	2020-09-30	5390000000.0	+36.2%	USD	10-K	2022-11-22
Annual	2021-09-30	7201000000.0	+33.6%	USD	10-K	2023-11-21
Annual	2022-09-30	6178000000.0	-14.2%	USD	10-K	2024-11-26
Annual	2023-09-30	9313000000.0	+50.7%	USD	10-K	2025-11-25
Annual	2024-09-30	10998000000.0	+18.1%	USD	10-K	2025-11-25
Annual	2025-09-30	11389000000.0	+3.6%	USD	10-K	2025-11-25

Accounts Receivable

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Inventory

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Current Assets

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Total Assets

Q: 40 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	27753211000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	28843431000.0	+3.9%	USD	10-Q	2016-08-08
Quarterly	2016-09-30	31486976000.0	+9.2%	USD	10-Q	2017-08-08
Quarterly	2016-12-31	31669390000.0	+0.6%	USD	10-Q	2017-02-08
Quarterly	2017-03-31	32928731000.0	+4.0%	USD	10-Q	2017-05-10
Quarterly	2017-06-30	33433426000.0	+1.5%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	34883456000.0	+4.3%	USD	10-Q	2018-08-07
Quarterly	2017-12-31	36084899000.0	+3.4%	USD	10-Q	2018-02-08
Quarterly	2018-03-31	36030871000.0	-0.1%	USD	10-Q	2018-05-09
Quarterly	2018-06-30	36364109000.0	+0.9%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	37413000000.0	+2.9%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	38544000000.0	+3.0%	USD	10-Q	2019-02-08
Quarterly	2019-03-31	38176000000.0	-1.0%	USD	10-Q	2019-05-09
Quarterly	2019-06-30	38677000000.0	+1.3%	USD	10-Q	2019-08-08
Quarterly	2019-09-30	38830000000.0	+0.4%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	40154000000.0	+3.4%	USD	10-Q	2020-02-07
Quarterly	2020-03-31	49809000000.0	+24.0%	USD	10-Q	2020-05-08
Quarterly	2020-06-30	44682000000.0	-10.3%	USD	10-Q	2020-08-07
Quarterly	2020-09-30	47482000000.0	+6.3%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	53657000000.0	+13.0%	USD	10-Q	2021-02-08
Quarterly	2021-03-31	56066000000.0	+4.5%	USD	10-Q	2021-05-07
Quarterly	2021-06-30	57161000000.0	+2.0%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	61891000000.0	+8.3%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	68461000000.0	+10.6%	USD	10-Q	2022-02-08
Quarterly	2022-03-31	73101000000.0	+6.8%	USD	10-Q	2022-05-09
Quarterly	2022-06-30	86111000000.0	+17.8%	USD	10-Q	2022-08-08
Quarterly	2022-09-30	80951000000.0	-6.0%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	77047000000.0	-4.8%	USD	10-Q	2023-02-03
Quarterly	2023-03-31	79180000000.0	+2.8%	USD	10-Q	2023-05-08
Quarterly	2023-06-30	77633000000.0	-2.0%	USD	10-Q	2023-08-04
Quarterly	2023-09-30	78360000000.0	+0.9%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	80130000000.0	+2.3%	USD	10-Q	2024-02-07
Quarterly	2024-03-31	81232000000.0	+1.4%	USD	10-Q	2024-05-07
Quarterly	2024-06-30	80628000000.0	-0.7%	USD	10-Q	2024-08-06
Quarterly	2024-09-30	82992000000.0	+2.9%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	82282000000.0	-0.9%	USD	10-Q	2025-02-07
Quarterly	2025-03-31	83132000000.0	+1.0%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	84815000000.0	+2.0%	USD	10-Q	2025-08-06
Quarterly	2025-09-30	88230000000.0	+4.0%	USD	10-Q	2026-02-06
Quarterly	2025-12-31	88760000000.0	+0.6%	USD	10-Q	2026-02-06
Annual	2016-09-30	31486976000.0	—	USD	10-K	2017-11-22
Annual	2017-09-30	34883456000.0	+10.8%	USD	10-K	2018-11-21
Annual	2018-09-30	37413000000.0	+7.3%	USD	10-K	2019-11-26
Annual	2019-09-30	38830000000.0	+3.8%	USD	10-K	2020-11-24
Annual	2020-09-30	47482000000.0	+22.3%	USD	10-K	2021-11-23
Annual	2021-09-30	61891000000.0	+30.3%	USD	10-K	2022-11-22
Annual	2022-09-30	80951000000.0	+30.8%	USD	10-K	2023-11-21
Annual	2023-09-30	78360000000.0	-3.2%	USD	10-K	2024-11-26
Annual	2024-09-30	82992000000.0	+5.9%	USD	10-K	2025-11-25
Annual	2025-09-30	88230000000.0	+6.3%	USD	10-K	2025-11-25

Current Liabilities

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Total Liabilities

Q: 40 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	22875972000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	23849301000.0	+4.3%	USD	10-Q	2016-08-08
Quarterly	2016-09-30	26424000000.0	+10.8%	USD	10-Q	2017-08-08
Quarterly	2016-12-31	26464789000.0	+0.2%	USD	10-Q	2017-02-08
Quarterly	2017-03-31	27600514000.0	+4.3%	USD	10-Q	2017-05-10
Quarterly	2017-06-30	27932676000.0	+1.2%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	29190105000.0	+4.5%	USD	10-Q	2018-08-07
Quarterly	2017-12-31	30281944000.0	+3.7%	USD	10-Q	2018-02-08
Quarterly	2018-03-31	29988649000.0	-1.0%	USD	10-Q	2018-05-09
Quarterly	2018-06-30	30114058000.0	+0.4%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	30961000000.0	+2.8%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	32319000000.0	+4.4%	USD	10-Q	2019-02-08
Quarterly	2019-03-31	31741000000.0	-1.8%	USD	10-Q	2019-05-09
Quarterly	2019-06-30	32113000000.0	+1.2%	USD	10-Q	2019-08-08
Quarterly	2019-09-30	32187000000.0	+0.2%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	33251000000.0	+3.3%	USD	10-Q	2020-02-07
Quarterly	2020-03-31	42975000000.0	+29.2%	USD	10-Q	2020-05-08
Quarterly	2020-06-30	37667000000.0	-12.4%	USD	10-Q	2020-08-07
Quarterly	2020-09-30	40306000000.0	+7.0%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	46219000000.0	+14.7%	USD	10-Q	2021-02-08
Quarterly	2021-03-31	48429000000.0	+4.8%	USD	10-Q	2021-05-07
Quarterly	2021-06-30	49243000000.0	+1.7%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	53588000000.0	+8.8%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	59809000000.0	+11.6%	USD	10-Q	2022-02-08
Quarterly	2022-03-31	64492000000.0	+7.8%	USD	10-Q	2022-05-09
Quarterly	2022-06-30	76619000000.0	+18.8%	USD	10-Q	2022-08-08
Quarterly	2022-09-30	71519000000.0	-6.7%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	67217000000.0	-6.0%	USD	10-Q	2023-02-03
Quarterly	2023-03-31	69211000000.0	+3.0%	USD	10-Q	2023-05-08
Quarterly	2023-06-30	67711000000.0	-2.2%	USD	10-Q	2023-08-04
Quarterly	2023-09-30	68173000000.0	+0.7%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	69349000000.0	+1.7%	USD	10-Q	2024-02-07
Quarterly	2024-03-31	70253000000.0	+1.3%	USD	10-Q	2024-05-07
Quarterly	2024-06-30	69438000000.0	-1.2%	USD	10-Q	2024-08-06
Quarterly	2024-09-30	71325000000.0	+2.7%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	70353000000.0	-1.4%	USD	10-Q	2025-02-07
Quarterly	2025-03-31	70905000000.0	+0.8%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	72554000000.0	+2.3%	USD	10-Q	2025-08-06
Quarterly	2025-09-30	75726000000.0	+4.4%	USD	10-Q	2026-02-06
Quarterly	2025-12-31	76186000000.0	+0.6%	USD	10-Q	2026-02-06
Annual	2016-09-30	26424000000.0	—	USD	10-K	2017-11-22
Annual	2017-09-30	29190105000.0	+10.5%	USD	10-K	2018-11-21
Annual	2018-09-30	30961000000.0	+6.1%	USD	10-K	2019-11-26
Annual	2019-09-30	32187000000.0	+4.0%	USD	10-K	2020-11-24
Annual	2020-09-30	40306000000.0	+25.2%	USD	10-K	2021-11-23
Annual	2021-09-30	53588000000.0	+33.0%	USD	10-K	2022-11-22
Annual	2022-09-30	71519000000.0	+33.5%	USD	10-K	2023-11-21
Annual	2023-09-30	68173000000.0	-4.7%	USD	10-K	2024-11-26
Annual	2024-09-30	71325000000.0	+4.6%	USD	10-K	2025-11-25
Annual	2025-09-30	75726000000.0	+6.2%	USD	10-K	2025-11-25

Stockholders' Equity

Q: 40 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	4783394000.0	—	USD	10-Q	2017-05-10
Quarterly	2016-06-30	4897796000.0	+2.4%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	5062976000.0	+3.4%	USD	10-Q	2017-08-08
Quarterly	2016-12-31	5204601000.0	+2.8%	USD	10-Q	2018-02-08
Quarterly	2017-03-31	5328217000.0	+2.4%	USD	10-Q	2018-05-09
Quarterly	2017-06-30	5500750000.0	+3.2%	USD	10-Q	2018-08-07
Quarterly	2017-09-30	5693351000.0	+3.5%	USD	10-Q	2018-08-07
Quarterly	2017-12-31	5803000000.0	+1.9%	USD	10-Q	2019-02-08
Quarterly	2018-03-31	6042000000.0	+4.1%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	6250000000.0	+3.4%	USD	10-Q	2019-08-08
Quarterly	2018-09-30	6452000000.0	+3.2%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	6225000000.0	-3.5%	USD	10-Q	2020-02-07
Quarterly	2019-03-31	6435000000.0	+3.4%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	6564000000.0	+2.0%	USD	10-Q	2020-08-07
Quarterly	2019-09-30	6643000000.0	+1.2%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	6903000000.0	+3.9%	USD	10-Q	2021-02-08
Quarterly	2020-03-31	6834000000.0	-1.0%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	7015000000.0	+2.6%	USD	10-Q	2021-08-09
Quarterly	2020-09-30	7176000000.0	+2.3%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	7438000000.0	+3.7%	USD	10-Q	2022-02-08
Quarterly	2021-03-31	7637000000.0	+2.7%	USD	10-Q	2022-05-09
Quarterly	2021-06-30	7918000000.0	+3.7%	USD	10-Q	2022-08-08
Quarterly	2021-09-30	8303000000.0	+4.9%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	8652000000.0	+4.2%	USD	10-Q	2023-02-03
Quarterly	2022-03-31	8609000000.0	-0.5%	USD	10-Q	2023-05-08
Quarterly	2022-06-30	9492000000.0	+10.3%	USD	10-Q	2023-08-04
Quarterly	2022-09-30	9432000000.0	-0.6%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	9830000000.0	+4.2%	USD	10-Q	2024-02-07
Quarterly	2023-03-31	9969000000.0	+1.4%	USD	10-Q	2024-05-07
Quarterly	2023-06-30	9922000000.0	-0.5%	USD	10-Q	2024-08-06
Quarterly	2023-09-30	10187000000.0	+2.7%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	10781000000.0	+5.8%	USD	10-Q	2025-02-07
Quarterly	2024-03-31	10979000000.0	+1.8%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	11190000000.0	+1.9%	USD	10-Q	2025-08-06
Quarterly	2024-09-30	11667000000.0	+4.3%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	11929000000.0	+2.2%	USD	10-Q	2026-02-06
Quarterly	2025-03-31	12227000000.0	+2.5%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	12261000000.0	+0.3%	USD	10-Q	2025-08-06
Quarterly	2025-09-30	12504000000.0	+2.0%	USD	10-Q	2026-02-06
Quarterly	2025-12-31	12574000000.0	+0.6%	USD	10-Q	2026-02-06
Annual	2016-09-30	5062976000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	5694000000.0	+12.5%	USD	10-K	2019-11-26
Annual	2018-09-30	6452000000.0	+13.3%	USD	10-K	2020-11-24
Annual	2019-09-30	6643000000.0	+3.0%	USD	10-K	2021-11-23
Annual	2020-09-30	7176000000.0	+8.0%	USD	10-K	2022-11-22
Annual	2021-09-30	8303000000.0	+15.7%	USD	10-K	2023-11-21
Annual	2022-09-30	9432000000.0	+13.6%	USD	10-K	2024-11-26
Annual	2023-09-30	10187000000.0	+8.0%	USD	10-K	2025-11-25
Annual	2024-09-30	11667000000.0	+14.5%	USD	10-K	2025-11-25
Annual	2025-09-30	12504000000.0	+7.2%	USD	10-K	2025-11-25

Long-Term Debt

Q: 4 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2021-09-30	8000000.0	—	USD	10-Q	2022-08-08
Quarterly	2022-06-30	3000000.0	-62.5%	USD	10-Q	2022-08-08
Quarterly	2022-09-30	1000000.0	-66.7%	USD	10-Q	2023-02-03
Quarterly	2022-12-31	0.0	-100.0%	USD	10-Q	2023-02-03

Cash Flow

Metrics: 4

Operating Cash Flow

Q: 25 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-12-31	422000000.0	—	USD	10-Q	2019-02-08
Quarterly	2018-03-31	606000000.0	+43.6%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	224000000.0	-63.0%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	225000000.0	+0.4%	USD	10-Q	2020-02-07
Quarterly	2019-03-31	20000000.0	-91.1%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	-101000000.0	-605.0%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	546000000.0	+640.6%	USD	10-Q	2021-02-08
Quarterly	2020-03-31	2943000000.0	+439.0%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	2655000000.0	-9.8%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	1921000000.0	-27.6%	USD	10-Q	2022-02-08
Quarterly	2021-03-31	736000000.0	-61.7%	USD	10-Q	2022-05-09
Quarterly	2021-06-30	2145000000.0	+191.4%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	-2287000000.0	-206.6%	USD	10-Q	2023-02-03
Quarterly	2022-03-31	-1170000000.0	+48.8%	USD	10-Q	2023-05-08
Quarterly	2022-06-30	4570000000.0	+490.6%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	-3136000000.0	-168.6%	USD	10-Q	2024-02-07
Quarterly	2023-03-31	-3760000000.0	-19.9%	USD	10-Q	2024-05-07
Quarterly	2023-06-30	-3948000000.0	-5.0%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	543000000.0	+113.8%	USD	10-Q	2025-02-07
Quarterly	2024-03-31	934000000.0	+72.0%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	1645000000.0	+76.1%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	830000000.0	-49.5%	USD	10-Q	2026-02-06
Quarterly	2025-03-31	947000000.0	+14.1%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	1638000000.0	+73.0%	USD	10-Q	2025-08-06
Quarterly	2025-12-31	-10000000.0	-100.6%	USD	10-Q	2026-02-06
Annual	2016-09-30	-573318000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	-125000000.0	+78.2%	USD	10-K	2019-11-26
Annual	2018-09-30	884000000.0	+807.2%	USD	10-K	2020-11-24
Annual	2019-09-30	577000000.0	-34.7%	USD	10-K	2021-11-23
Annual	2020-09-30	4073000000.0	+605.9%	USD	10-K	2022-11-22
Annual	2021-09-30	6647000000.0	+63.2%	USD	10-K	2023-11-21
Annual	2022-09-30	72000000.0	-98.9%	USD	10-K	2024-11-26
Annual	2023-09-30	-3514000000.0	-4980.6%	USD	10-K	2025-11-25
Annual	2024-09-30	2155000000.0	+161.3%	USD	10-K	2025-11-25
Annual	2025-09-30	2434000000.0	+12.9%	USD	10-K	2025-11-25

Investing Cash Flow

Q: 25 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-12-31	-1074000000.0	—	USD	10-Q	2019-02-08
Quarterly	2018-03-31	-1815000000.0	-69.0%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	-2498000000.0	-37.6%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	-533000000.0	+78.7%	USD	10-Q	2020-02-07
Quarterly	2019-03-31	-910000000.0	-70.7%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	-1386000000.0	-52.3%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	-502000000.0	+63.8%	USD	10-Q	2021-02-08
Quarterly	2020-03-31	-2090000000.0	-316.3%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	-3020000000.0	-44.5%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	-1123000000.0	+62.8%	USD	10-Q	2022-02-08
Quarterly	2021-03-31	-2437000000.0	-117.0%	USD	10-Q	2022-05-09
Quarterly	2021-06-30	-3157000000.0	-29.5%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	-1555000000.0	+50.7%	USD	10-Q	2023-02-03
Quarterly	2022-03-31	-2403000000.0	-54.5%	USD	10-Q	2023-05-08
Quarterly	2022-06-30	-5119000000.0	-113.0%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	-666000000.0	+87.0%	USD	10-Q	2024-02-07
Quarterly	2023-03-31	-319000000.0	+52.1%	USD	10-Q	2024-05-07
Quarterly	2023-06-30	68000000.0	+121.3%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	-176000000.0	-358.8%	USD	10-Q	2025-02-07
Quarterly	2024-03-31	-109000000.0	+38.1%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	-757000000.0	-594.5%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	-937000000.0	-23.8%	USD	10-Q	2026-02-06
Quarterly	2025-03-31	-1596000000.0	-70.3%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	-2898000000.0	-81.6%	USD	10-Q	2025-08-06
Quarterly	2025-12-31	-1865000000.0	+35.6%	USD	10-Q	2026-02-06
Annual	2016-09-30	-2917903000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	-3376000000.0	-15.7%	USD	10-K	2019-11-26
Annual	2018-09-30	-3476000000.0	-3.0%	USD	10-K	2020-11-24
Annual	2019-09-30	-1897000000.0	+45.4%	USD	10-K	2021-11-23
Annual	2020-09-30	-4985000000.0	-162.8%	USD	10-K	2022-11-22
Annual	2021-09-30	-5140000000.0	-3.1%	USD	10-K	2023-11-21
Annual	2022-09-30	-7151000000.0	-39.1%	USD	10-K	2024-11-26
Annual	2023-09-30	-274000000.0	+96.2%	USD	10-K	2025-11-25
Annual	2024-09-30	-968000000.0	-253.3%	USD	10-K	2025-11-25
Annual	2025-09-30	-4321000000.0	-346.4%	USD	10-K	2025-11-25

Financing Cash Flow

Q: 25 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-12-31	980000000.0	—	USD	10-Q	2019-02-08
Quarterly	2018-03-31	312000000.0	-68.2%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	1042000000.0	+234.0%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	1526000000.0	+46.4%	USD	10-Q	2020-02-07
Quarterly	2019-03-31	1099000000.0	-28.0%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	1510000000.0	+37.4%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	654000000.0	-56.7%	USD	10-Q	2021-02-08
Quarterly	2020-03-31	7951000000.0	+1115.7%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	3258000000.0	-59.0%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	891000000.0	-72.7%	USD	10-Q	2022-02-08
Quarterly	2021-03-31	2249000000.0	+152.4%	USD	10-Q	2022-05-09
Quarterly	2021-06-30	3128000000.0	+39.1%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	1497000000.0	-52.1%	USD	10-Q	2023-02-03
Quarterly	2022-03-31	2025000000.0	+35.3%	USD	10-Q	2023-05-08
Quarterly	2022-06-30	4598000000.0	+127.1%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	221000000.0	-95.2%	USD	10-Q	2024-02-07
Quarterly	2023-03-31	2522000000.0	+1041.2%	USD	10-Q	2024-05-07
Quarterly	2023-06-30	1089000000.0	-56.8%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	907000000.0	-16.7%	USD	10-Q	2025-02-07
Quarterly	2024-03-31	266000000.0	-70.7%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	-756000000.0	-384.2%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	-447000000.0	+40.9%	USD	10-Q	2026-02-06
Quarterly	2025-03-31	-463000000.0	-3.6%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	-171000000.0	+63.1%	USD	10-Q	2025-08-06
Quarterly	2025-12-31	629000000.0	+467.8%	USD	10-Q	2026-02-06
Annual	2016-09-30	2540479000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	4065000000.0	+60.0%	USD	10-K	2019-11-26
Annual	2018-09-30	1420000000.0	-65.1%	USD	10-K	2020-11-24
Annual	2019-09-30	1373000000.0	-3.3%	USD	10-K	2021-11-23
Annual	2020-09-30	4574000000.0	+233.1%	USD	10-K	2022-11-22
Annual	2021-09-30	5232000000.0	+14.4%	USD	10-K	2023-11-21
Annual	2022-09-30	5879000000.0	+12.4%	USD	10-K	2024-11-26
Annual	2023-09-30	1438000000.0	-75.5%	USD	10-K	2025-11-25
Annual	2024-09-30	438000000.0	-69.5%	USD	10-K	2025-11-25
Annual	2025-09-30	2361000000.0	+439.0%	USD	10-K	2025-11-25

Capital Expenditures

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	58180000.0	—	USD	10-Q	2017-05-10
Quarterly	2016-06-30	86518000.0	+48.7%	USD	10-Q	2017-08-08
Quarterly	2016-12-31	78371000.0	-9.4%	USD	10-Q	2018-02-08
Quarterly	2017-03-31	123052000.0	+57.0%	USD	10-Q	2018-05-09
Quarterly	2017-06-30	152715000.0	+24.1%	USD	10-Q	2018-08-07
Quarterly	2017-12-31	36000000.0	-76.4%	USD	10-Q	2019-02-08
Quarterly	2018-03-31	70000000.0	+94.4%	USD	10-Q	2019-05-09
Quarterly	2018-06-30	96000000.0	+37.1%	USD	10-Q	2019-08-08
Quarterly	2018-12-31	27000000.0	-71.9%	USD	10-Q	2020-02-07
Quarterly	2019-03-31	59000000.0	+118.5%	USD	10-Q	2020-05-08
Quarterly	2019-06-30	102000000.0	+72.9%	USD	10-Q	2020-08-07
Quarterly	2019-12-31	36000000.0	-64.7%	USD	10-Q	2021-02-08
Quarterly	2020-03-31	71000000.0	+97.2%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	97000000.0	+36.6%	USD	10-Q	2021-08-09
Quarterly	2020-12-31	25000000.0	-74.2%	USD	10-Q	2022-02-08
Quarterly	2021-03-31	62000000.0	+148.0%	USD	10-Q	2022-05-09
Quarterly	2021-06-30	99000000.0	+59.7%	USD	10-Q	2022-08-08
Quarterly	2021-12-31	19000000.0	-80.8%	USD	10-Q	2023-02-03
Quarterly	2022-03-31	42000000.0	+121.1%	USD	10-Q	2023-05-08
Quarterly	2022-06-30	68000000.0	+61.9%	USD	10-Q	2023-08-04
Quarterly	2022-12-31	27000000.0	-60.3%	USD	10-Q	2024-02-07
Quarterly	2023-03-31	69000000.0	+155.6%	USD	10-Q	2024-05-07
Quarterly	2023-06-30	122000000.0	+76.8%	USD	10-Q	2024-08-06
Quarterly	2023-12-31	50000000.0	-59.0%	USD	10-Q	2025-02-07
Quarterly	2024-03-31	99000000.0	+98.0%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	155000000.0	+56.6%	USD	10-Q	2025-08-06
Quarterly	2024-12-31	41000000.0	-73.5%	USD	10-Q	2026-02-06
Quarterly	2025-03-31	87000000.0	+112.2%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	144000000.0	+65.5%	USD	10-Q	2025-08-06
Quarterly	2025-12-31	46000000.0	-68.1%	USD	10-Q	2026-02-06
Annual	2016-09-30	121733000.0	—	USD	10-K	2018-11-21
Annual	2017-09-30	190000000.0	+56.1%	USD	10-K	2019-11-26
Annual	2018-09-30	134000000.0	-29.5%	USD	10-K	2020-11-24
Annual	2019-09-30	138000000.0	+3.0%	USD	10-K	2021-11-23
Annual	2020-09-30	124000000.0	-10.1%	USD	10-K	2022-11-22
Annual	2021-09-30	74000000.0	-40.3%	USD	10-K	2023-11-21
Annual	2022-09-30	91000000.0	+23.0%	USD	10-K	2024-11-26
Annual	2023-09-30	173000000.0	+90.1%	USD	10-K	2025-11-25
Annual	2024-09-30	205000000.0	+18.5%	USD	10-K	2025-11-25
Annual	2025-09-30	188000000.0	-8.3%	USD	10-K	2025-11-25

Share Data

Metrics: 4

Shares Outstanding

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-06-30	141298720.0	—	shares	10-Q	2016-08-08
Quarterly	2016-09-30	141544511.0	+0.2%	shares	10-Q	2017-08-08
Quarterly	2016-12-31	142930077.0	+1.0%	shares	10-Q	2017-02-08
Quarterly	2017-03-31	143542965.0	+0.4%	shares	10-Q	2017-05-10
Quarterly	2017-06-30	143853338.0	+0.2%	shares	10-Q	2017-08-08
Quarterly	2017-09-30	144096521.0	+0.2%	shares	10-Q	2018-08-07
Quarterly	2017-12-31	145153686.0	+0.7%	shares	10-Q	2018-02-08
Quarterly	2018-03-31	145551740.0	+0.3%	shares	10-Q	2018-05-09
Quarterly	2018-06-30	145754690.0	+0.1%	shares	10-Q	2018-08-07
Quarterly	2018-09-30	145642437.0	-0.1%	shares	10-Q	2019-08-08
Quarterly	2018-12-31	140616735.0	-3.5%	shares	10-Q	2019-02-08
Quarterly	2019-03-31	140439495.0	-0.1%	shares	10-Q	2019-05-09
Quarterly	2019-06-30	139666546.0	-0.6%	shares	10-Q	2019-08-08
Quarterly	2019-09-30	137841952.0	-1.3%	shares	10-Q	2020-08-07
Quarterly	2019-12-31	138937307.0	+0.8%	shares	10-Q	2020-02-07
Quarterly	2020-03-31	136787387.0	-1.5%	shares	10-Q	2020-05-08
Quarterly	2020-06-30	137025724.0	+0.2%	shares	10-Q	2020-08-07
Quarterly	2020-09-30	136556559.0	-0.3%	shares	10-Q	2021-08-09
Quarterly	2020-12-31	137378992.0	+0.6%	shares	10-Q	2021-02-08
Quarterly	2021-03-31	137155669.0	-0.2%	shares	10-Q	2021-05-07
Quarterly	2021-06-30	136948422.0	-0.2%	shares	10-Q	2021-08-09
Quarterly	2021-09-30	205738821.0	+50.2%	shares	10-Q	2022-08-08
Quarterly	2021-12-31	207465632.0	+0.8%	shares	10-Q	2022-02-08
Quarterly	2022-03-31	207897379.0	+0.2%	shares	10-Q	2022-05-09
Quarterly	2022-06-30	215478025.0	+3.6%	shares	10-Q	2022-08-08
Quarterly	2022-09-30	215100000.0	-0.2%	shares	10-Q	2024-08-06
Quarterly	2022-12-31	215000000.0	-0.0%	shares	10-Q	2024-05-07
Quarterly	2023-03-31	211600000.0	-1.6%	shares	10-Q	2024-08-06
Quarterly	2023-06-30	208500000.0	-1.5%	shares	10-Q	2024-08-06
Quarterly	2023-09-30	208800000.0	+0.1%	shares	10-Q	2025-08-06
Quarterly	2023-12-31	208700000.0	-0.0%	shares	10-Q	2025-05-07
Quarterly	2024-03-31	207300000.0	-0.7%	shares	10-Q	2025-08-06
Quarterly	2024-06-30	205600000.0	-0.8%	shares	10-Q	2025-08-06
Quarterly	2024-09-30	203300000.0	-1.1%	shares	10-Q	2026-02-06
Quarterly	2024-12-31	204600000.0	+0.6%	shares	10-Q	2026-02-06
Quarterly	2025-03-31	203100000.0	-0.7%	shares	10-Q	2025-08-06
Quarterly	2025-06-30	199985079.0	-1.5%	shares	10-Q	2025-08-06
Quarterly	2025-09-30	198139594.0	-0.9%	shares	10-Q	2026-02-06
Quarterly	2025-12-31	197032070.0	-0.6%	shares	10-Q	2026-02-06
Annual	2016-09-30	141544511.0	—	shares	10-K	2017-11-22
Annual	2017-09-30	144096521.0	+1.8%	shares	10-K	2018-11-21
Annual	2018-09-30	145642437.0	+1.1%	shares	10-K	2019-11-26
Annual	2019-09-30	137841952.0	-5.4%	shares	10-K	2020-11-24
Annual	2020-09-30	204900000.0	+48.6%	shares	10-K	2023-11-21
Annual	2021-09-30	205700000.0	+0.4%	shares	10-K	2024-11-26
Annual	2022-09-30	215100000.0	+4.6%	shares	10-K	2025-11-25
Annual	2023-09-30	208800000.0	-2.9%	shares	10-K	2025-11-25
Annual	2024-09-30	203291449.0	-2.6%	shares	10-K	2025-11-25
Annual	2025-09-30	198139594.0	-2.5%	shares	10-K	2025-11-25

Shares Issued

Q: 40 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	150853426.0	—	shares	10-Q	2016-05-06
Quarterly	2016-06-30	151213530.0	+0.2%	shares	10-Q	2016-08-08
Quarterly	2016-09-30	151424947.0	+0.1%	shares	10-Q	2017-08-08
Quarterly	2016-12-31	153122715.0	+1.1%	shares	10-Q	2017-02-08
Quarterly	2017-03-31	153716695.0	+0.4%	shares	10-Q	2017-05-10
Quarterly	2017-06-30	154046800.0	+0.2%	shares	10-Q	2017-08-08
Quarterly	2017-09-30	154228235.0	+0.1%	shares	10-Q	2018-08-07
Quarterly	2017-12-31	155497352.0	+0.8%	shares	10-Q	2018-02-08
Quarterly	2018-03-31	155915215.0	+0.3%	shares	10-Q	2018-05-09
Quarterly	2018-06-30	156126130.0	+0.1%	shares	10-Q	2018-08-07
Quarterly	2018-09-30	156363615.0	+0.2%	shares	10-Q	2019-08-08
Quarterly	2018-12-31	157645318.0	+0.8%	shares	10-Q	2019-02-08
Quarterly	2019-03-31	158086495.0	+0.3%	shares	10-Q	2019-05-09
Quarterly	2019-06-30	158316880.0	+0.1%	shares	10-Q	2019-08-08
Quarterly	2019-09-30	158435030.0	+0.1%	shares	10-Q	2020-08-07
Quarterly	2019-12-31	158571983.0	+0.1%	shares	10-Q	2020-02-07
Quarterly	2020-03-31	158731812.0	+0.1%	shares	10-Q	2020-05-08
Quarterly	2020-06-30	158909194.0	+0.1%	shares	10-Q	2020-08-07
Quarterly	2020-09-30	159007158.0	+0.1%	shares	10-Q	2021-08-09
Quarterly	2020-12-31	159127724.0	+0.1%	shares	10-Q	2021-02-08
Quarterly	2021-03-31	159231968.0	+0.1%	shares	10-Q	2021-05-07
Quarterly	2021-06-30	159303913.0	+0.0%	shares	10-Q	2021-08-09
Quarterly	2021-09-30	239062254.0	+50.1%	shares	10-Q	2022-08-08
Quarterly	2021-12-31	239160005.0	+0.0%	shares	10-Q	2022-02-08
Quarterly	2022-03-31	239295583.0	+0.1%	shares	10-Q	2022-05-09
Quarterly	2022-06-30	247945777.0	+3.6%	shares	10-Q	2022-08-08
Quarterly	2022-09-30	248018564.0	+0.0%	shares	10-Q	2023-08-04
Quarterly	2022-12-31	248081414.0	+0.0%	shares	10-Q	2023-02-03
Quarterly	2023-03-31	248323901.0	+0.1%	shares	10-Q	2023-05-08
Quarterly	2023-06-30	248561711.0	+0.1%	shares	10-Q	2023-08-04
Quarterly	2023-09-30	248728805.0	+0.1%	shares	10-Q	2024-08-06
Quarterly	2023-12-31	249682751.0	+0.4%	shares	10-Q	2024-02-07
Quarterly	2024-03-31	249799231.0	+0.0%	shares	10-Q	2024-05-07
Quarterly	2024-06-30	249886619.0	+0.0%	shares	10-Q	2024-08-06
Quarterly	2024-09-30	249972182.0	+0.0%	shares	10-Q	2025-08-06
Quarterly	2024-12-31	250025894.0	+0.0%	shares	10-Q	2025-02-07
Quarterly	2025-03-31	250076677.0	+0.0%	shares	10-Q	2025-05-07
Quarterly	2025-06-30	250080849.0	+0.0%	shares	10-Q	2025-08-06
Quarterly	2025-09-30	250084168.0	+0.0%	shares	10-Q	2026-02-06
Quarterly	2025-12-31	250084168.0	+0.0%	shares	10-Q	2026-02-06
Annual	2016-09-30	151424947.0	—	shares	10-K	2017-11-22
Annual	2017-09-30	154228235.0	+1.9%	shares	10-K	2018-11-21
Annual	2018-09-30	156363615.0	+1.4%	shares	10-K	2019-11-26
Annual	2019-09-30	158435030.0	+1.3%	shares	10-K	2020-11-24
Annual	2020-09-30	238510737.0	+50.5%	shares	10-K	2021-11-23
Annual	2021-09-30	239062254.0	+0.2%	shares	10-K	2022-11-22
Annual	2022-09-30	248018564.0	+3.7%	shares	10-K	2023-11-21
Annual	2023-09-30	248728805.0	+0.3%	shares	10-K	2024-11-26
Annual	2024-09-30	249972182.0	+0.5%	shares	10-K	2025-11-25
Annual	2025-09-30	250084168.0	+0.0%	shares	10-K	2025-11-25

Weighted Avg Shares Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	141472000.0	—	shares	10-Q	2017-05-10
Quarterly	2016-06-30	141165000.0	-0.2%	shares	10-Q	2017-08-08
Quarterly	2016-12-31	142110000.0	+0.7%	shares	10-Q	2018-02-08
Quarterly	2017-03-31	143367000.0	+0.9%	shares	10-Q	2018-05-09
Quarterly	2017-06-30	143712000.0	+0.2%	shares	10-Q	2018-08-07
Quarterly	2017-12-31	144500000.0	+0.5%	shares	10-Q	2019-02-08
Quarterly	2018-03-31	145400000.0	+0.6%	shares	10-Q	2019-05-09
Quarterly	2018-06-30	145600000.0	+0.1%	shares	10-Q	2019-08-08
Quarterly	2018-12-31	144200000.0	-1.0%	shares	10-Q	2020-02-07
Quarterly	2019-03-31	140800000.0	-2.4%	shares	10-Q	2020-05-08
Quarterly	2019-06-30	140400000.0	-0.3%	shares	10-Q	2020-08-07
Quarterly	2019-12-31	138300000.0	-1.5%	shares	10-Q	2021-02-08
Quarterly	2020-03-31	138400000.0	+0.1%	shares	10-Q	2021-05-07
Quarterly	2020-06-30	137100000.0	-0.9%	shares	10-Q	2021-08-09
Quarterly	2020-12-31	205200000.0	+49.7%	shares	10-Q	2022-02-08
Quarterly	2021-03-31	206700000.0	+0.7%	shares	10-Q	2022-05-09
Quarterly	2021-06-30	205800000.0	-0.4%	shares	10-Q	2022-08-08
Quarterly	2021-12-31	206300000.0	+0.2%	shares	10-Q	2023-02-03
Quarterly	2022-03-31	207700000.0	+0.7%	shares	10-Q	2023-05-08
Quarterly	2022-06-30	210700000.0	+1.4%	shares	10-Q	2023-08-04
Quarterly	2022-12-31	214700000.0	+1.9%	shares	10-Q	2024-02-07
Quarterly	2023-03-31	214300000.0	-0.2%	shares	10-Q	2024-05-07
Quarterly	2023-06-30	210100000.0	-2.0%	shares	10-Q	2024-08-06
Quarterly	2023-12-31	208600000.0	-0.7%	shares	10-Q	2025-02-07
Quarterly	2024-03-31	208300000.0	-0.1%	shares	10-Q	2025-05-07
Quarterly	2024-06-30	206800000.0	-0.7%	shares	10-Q	2025-08-06
Quarterly	2024-12-31	203700000.0	-1.5%	shares	10-Q	2026-02-06
Quarterly	2025-03-31	204300000.0	+0.3%	shares	10-Q	2025-05-07
Quarterly	2025-06-30	201200000.0	-1.5%	shares	10-Q	2025-08-06
Quarterly	2025-12-31	197100000.0	-2.0%	shares	10-Q	2026-02-06
Annual	2016-09-30	141773000.0	—	shares	10-K	2018-11-21
Annual	2017-09-30	143300000.0	+1.1%	shares	10-K	2019-11-26
Annual	2018-09-30	145300000.0	+1.4%	shares	10-K	2020-11-24
Annual	2019-09-30	211500000.0	+45.6%	shares	10-K	2021-11-23
Annual	2020-09-30	206400000.0	-2.4%	shares	10-K	2022-11-22
Annual	2021-09-30	205700000.0	-0.3%	shares	10-K	2023-11-21
Annual	2022-09-30	209900000.0	+2.0%	shares	10-K	2024-11-26
Annual	2023-09-30	211800000.0	+0.9%	shares	10-K	2025-11-25
Annual	2024-09-30	207100000.0	-2.2%	shares	10-K	2025-11-25
Annual	2025-09-30	202000000.0	-2.5%	shares	10-K	2025-11-25

Weighted Avg Shares Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	144012000.0	—	shares	10-Q	2017-05-10
Quarterly	2016-06-30	143952000.0	-0.0%	shares	10-Q	2017-08-08
Quarterly	2016-12-31	145675000.0	+1.2%	shares	10-Q	2018-02-08
Quarterly	2017-03-31	146779000.0	+0.8%	shares	10-Q	2018-05-09
Quarterly	2017-06-30	147103000.0	+0.2%	shares	10-Q	2018-08-07
Quarterly	2017-12-31	148300000.0	+0.8%	shares	10-Q	2019-02-08
Quarterly	2018-03-31	149000000.0	+0.5%	shares	10-Q	2019-05-09
Quarterly	2018-06-30	149400000.0	+0.3%	shares	10-Q	2019-08-08
Quarterly	2018-12-31	147300000.0	-1.4%	shares	10-Q	2020-02-07
Quarterly	2019-03-31	143900000.0	-2.3%	shares	10-Q	2020-05-08
Quarterly	2019-06-30	143600000.0	-0.2%	shares	10-Q	2020-08-07
Quarterly	2019-12-31	141500000.0	-1.5%	shares	10-Q	2021-02-08
Quarterly	2020-03-31	141100000.0	-0.3%	shares	10-Q	2021-05-07
Quarterly	2020-06-30	139400000.0	-1.2%	shares	10-Q	2021-08-09
Quarterly	2020-12-31	209600000.0	+50.4%	shares	10-Q	2022-02-08
Quarterly	2021-03-31	211800000.0	+1.0%	shares	10-Q	2022-05-09
Quarterly	2021-06-30	211700000.0	-0.0%	shares	10-Q	2022-08-08
Quarterly	2021-12-31	212400000.0	+0.3%	shares	10-Q	2023-02-03
Quarterly	2022-03-31	213000000.0	+0.3%	shares	10-Q	2023-05-08
Quarterly	2022-06-30	215700000.0	+1.3%	shares	10-Q	2023-08-04
Quarterly	2022-12-31	220400000.0	+2.2%	shares	10-Q	2024-02-07
Quarterly	2023-03-31	219200000.0	-0.5%	shares	10-Q	2024-05-07
Quarterly	2023-06-30	214800000.0	-2.0%	shares	10-Q	2024-08-06
Quarterly	2023-12-31	213800000.0	-0.5%	shares	10-Q	2025-02-07
Quarterly	2024-03-31	213400000.0	-0.2%	shares	10-Q	2025-05-07
Quarterly	2024-06-30	212300000.0	-0.5%	shares	10-Q	2025-08-06
Quarterly	2024-12-31	209200000.0	-1.5%	shares	10-Q	2026-02-06
Quarterly	2025-03-31	208700000.0	-0.2%	shares	10-Q	2025-05-07
Quarterly	2025-06-30	205500000.0	-1.5%	shares	10-Q	2025-08-06
Quarterly	2025-12-31	201400000.0	-2.0%	shares	10-Q	2026-02-06
Annual	2016-09-30	144513000.0	—	shares	10-K	2018-11-21
Annual	2017-09-30	146600000.0	+1.4%	shares	10-K	2019-11-26
Annual	2018-09-30	148800000.0	+1.5%	shares	10-K	2020-11-24
Annual	2019-09-30	216000000.0	+45.2%	shares	10-K	2021-11-23
Annual	2020-09-30	210300000.0	-2.6%	shares	10-K	2022-11-22
Annual	2021-09-30	211200000.0	+0.4%	shares	10-K	2023-11-21
Annual	2022-09-30	215300000.0	+1.9%	shares	10-K	2024-11-26
Annual	2023-09-30	216900000.0	+0.7%	shares	10-K	2025-11-25
Annual	2024-09-30	212300000.0	-2.1%	shares	10-K	2025-11-25
Annual	2025-09-30	206600000.0	-2.7%	shares	10-K	2025-11-25

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

N/A

Total Liabilities (latest annual)

75,726,000,000

Current Liabilities (latest annual)

N/A

Metrics

Metrics: 5

Asset Turnover

Efficiency Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0483	—	ratio	10-Q	2017-05-10
Quarterly	2016-06-30	0.0481	-0.5%	ratio	10-Q	2017-08-08
Quarterly	2016-12-31	0.0483	+0.4%	ratio	10-Q	2018-02-08
Quarterly	2017-03-31	0.0486	+0.7%	ratio	10-Q	2018-05-09
Quarterly	2017-06-30	0.0497	+2.4%	ratio	10-Q	2018-08-07
Quarterly	2017-12-31	0.0489	-1.6%	ratio	10-Q	2019-02-08
Quarterly	2018-03-31	0.0515	+5.3%	ratio	10-Q	2019-05-09
Quarterly	2018-06-30	0.0520	+0.9%	ratio	10-Q	2019-08-08
Quarterly	2018-12-31	0.0520	-0.0%	ratio	10-Q	2020-02-07
Quarterly	2019-03-31	0.0507	-2.6%	ratio	10-Q	2020-05-08
Quarterly	2019-06-30	0.0517	+2.1%	ratio	10-Q	2020-08-07
Quarterly	2019-12-31	0.0513	-0.8%	ratio	10-Q	2021-02-08
Quarterly	2020-03-31	0.0424	-17.4%	ratio	10-Q	2021-05-07
Quarterly	2020-06-30	0.0420	-0.9%	ratio	10-Q	2021-08-09
Quarterly	2020-12-31	0.0421	+0.3%	ratio	10-Q	2022-02-08
Quarterly	2021-03-31	0.0430	+2.0%	ratio	10-Q	2022-05-09
Quarterly	2021-06-30	0.0439	+2.2%	ratio	10-Q	2022-08-08
Quarterly	2021-12-31	0.0412	-6.3%	ratio	10-Q	2023-02-03
Quarterly	2022-03-31	0.0371	-9.9%	ratio	10-Q	2023-05-08
Quarterly	2022-06-30	0.0323	-13.0%	ratio	10-Q	2023-08-04
Quarterly	2022-12-31	0.0393	+21.8%	ratio	10-Q	2024-02-07
Quarterly	2023-03-31	0.0399	+1.5%	ratio	10-Q	2024-05-07
Quarterly	2023-06-30	0.0424	+6.4%	ratio	10-Q	2024-08-06
Quarterly	2023-12-31	0.0439	+3.6%	ratio	10-Q	2025-02-07
Quarterly	2024-03-31	0.0448	+2.0%	ratio	10-Q	2025-05-07
Quarterly	2024-06-30	0.0467	+4.2%	ratio	10-Q	2025-08-06
Quarterly	2024-12-31	0.0490	+5.1%	ratio	10-Q	2026-02-06
Quarterly	2025-03-31	0.0463	-5.7%	ratio	10-Q	2025-05-07
Quarterly	2025-06-30	0.0453	-2.1%	ratio	10-Q	2025-08-06
Quarterly	2025-12-31	0.0470	+3.9%	ratio	10-Q	2026-02-06
Annual	2016-09-30	0.1753	—	ratio	10-K	2018-11-21
Annual	2017-09-30	0.1871	+6.7%	ratio	10-K	2019-11-26
Annual	2018-09-30	0.1998	+6.8%	ratio	10-K	2020-11-24
Annual	2019-09-30	0.2066	+3.4%	ratio	10-K	2021-11-23
Annual	2020-09-30	0.1720	-16.7%	ratio	10-K	2022-11-22
Annual	2021-09-30	0.1601	-6.9%	ratio	10-K	2023-11-21
Annual	2022-09-30	0.1397	-12.8%	ratio	10-K	2024-11-26
Annual	2023-09-30	0.1658	+18.7%	ratio	10-K	2025-11-25
Annual	2024-09-30	0.1798	+8.5%	ratio	10-K	2025-11-25
Annual	2025-09-30	0.1803	+0.3%	ratio	10-K	2025-11-25

Debt to Equity

Leverage Q: 40 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	4.7824	—	ratio	10-Q	2016-05-06
Quarterly	2016-06-30	4.8694	+1.8%	ratio	10-Q	2016-08-08
Quarterly	2016-09-30	5.2191	+7.2%	ratio	10-Q	2017-08-08
Quarterly	2016-12-31	5.0849	-2.6%	ratio	10-Q	2017-02-08
Quarterly	2017-03-31	5.1801	+1.9%	ratio	10-Q	2017-05-10
Quarterly	2017-06-30	5.0780	-2.0%	ratio	10-Q	2017-08-08
Quarterly	2017-09-30	5.1271	+1.0%	ratio	10-Q	2018-08-07
Quarterly	2017-12-31	5.2183	+1.8%	ratio	10-Q	2018-02-08
Quarterly	2018-03-31	4.9634	-4.9%	ratio	10-Q	2018-05-09
Quarterly	2018-06-30	4.8182	-2.9%	ratio	10-Q	2018-08-07
Quarterly	2018-09-30	4.7987	-0.4%	ratio	10-Q	2019-08-08
Quarterly	2018-12-31	5.1918	+8.2%	ratio	10-Q	2019-02-08
Quarterly	2019-03-31	4.9326	-5.0%	ratio	10-Q	2019-05-09
Quarterly	2019-06-30	4.8923	-0.8%	ratio	10-Q	2019-08-08
Quarterly	2019-09-30	4.8453	-1.0%	ratio	10-Q	2020-08-07
Quarterly	2019-12-31	4.8169	-0.6%	ratio	10-Q	2020-02-07
Quarterly	2020-03-31	6.2884	+30.5%	ratio	10-Q	2020-05-08
Quarterly	2020-06-30	5.3695	-14.6%	ratio	10-Q	2020-08-07
Quarterly	2020-09-30	5.6168	+4.6%	ratio	10-Q	2021-08-09
Quarterly	2020-12-31	6.2139	+10.6%	ratio	10-Q	2021-02-08
Quarterly	2021-03-31	6.3414	+2.1%	ratio	10-Q	2021-05-07
Quarterly	2021-06-30	6.2191	-1.9%	ratio	10-Q	2021-08-09
Quarterly	2021-09-30	6.4541	+3.8%	ratio	10-Q	2022-08-08
Quarterly	2021-12-31	6.9127	+7.1%	ratio	10-Q	2022-02-08
Quarterly	2022-03-31	7.4912	+8.4%	ratio	10-Q	2022-05-09
Quarterly	2022-06-30	8.0720	+7.8%	ratio	10-Q	2022-08-08
Quarterly	2022-09-30	7.5826	-6.1%	ratio	10-Q	2023-08-04
Quarterly	2022-12-31	6.8379	-9.8%	ratio	10-Q	2023-02-03
Quarterly	2023-03-31	6.9426	+1.5%	ratio	10-Q	2023-05-08
Quarterly	2023-06-30	6.8243	-1.7%	ratio	10-Q	2023-08-04
Quarterly	2023-09-30	6.6922	-1.9%	ratio	10-Q	2024-08-06
Quarterly	2023-12-31	6.4325	-3.9%	ratio	10-Q	2024-02-07
Quarterly	2024-03-31	6.3989	-0.5%	ratio	10-Q	2024-05-07
Quarterly	2024-06-30	6.2054	-3.0%	ratio	10-Q	2024-08-06
Quarterly	2024-09-30	6.1134	-1.5%	ratio	10-Q	2025-08-06
Quarterly	2024-12-31	5.8976	-3.5%	ratio	10-Q	2025-02-07
Quarterly	2025-03-31	5.7991	-1.7%	ratio	10-Q	2025-05-07
Quarterly	2025-06-30	5.9175	+2.0%	ratio	10-Q	2025-08-06
Quarterly	2025-09-30	6.0561	+2.3%	ratio	10-Q	2026-02-06
Quarterly	2025-12-31	6.0590	+0.0%	ratio	10-Q	2026-02-06
Annual	2016-09-30	5.2191	—	ratio	10-K	2017-11-22
Annual	2017-09-30	5.1265	-1.8%	ratio	10-K	2018-11-21
Annual	2018-09-30	4.7987	-6.4%	ratio	10-K	2019-11-26
Annual	2019-09-30	4.8453	+1.0%	ratio	10-K	2020-11-24
Annual	2020-09-30	5.6168	+15.9%	ratio	10-K	2021-11-23
Annual	2021-09-30	6.4541	+14.9%	ratio	10-K	2022-11-22
Annual	2022-09-30	7.5826	+17.5%	ratio	10-K	2023-11-21
Annual	2023-09-30	6.6922	-11.7%	ratio	10-K	2024-11-26
Annual	2024-09-30	6.1134	-8.6%	ratio	10-K	2025-11-25
Annual	2025-09-30	6.0561	-0.9%	ratio	10-K	2025-11-25

Net Margin

Profitability Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0908	—	ratio	10-Q	2017-05-10
Quarterly	2016-06-30	0.0956	+5.2%	ratio	10-Q	2017-08-08
Quarterly	2016-12-31	0.0966	+1.1%	ratio	10-Q	2018-02-08
Quarterly	2017-03-31	0.0678	-29.8%	ratio	10-Q	2018-05-09
Quarterly	2017-06-30	0.1114	+64.3%	ratio	10-Q	2018-08-07
Quarterly	2017-12-31	0.0674	-39.5%	ratio	10-Q	2019-02-08
Quarterly	2018-03-31	0.1309	+94.2%	ratio	10-Q	2019-05-09
Quarterly	2018-06-30	0.1227	-6.2%	ratio	10-Q	2019-08-08
Quarterly	2018-12-31	0.1243	+1.3%	ratio	10-Q	2020-02-07
Quarterly	2019-03-31	0.1350	+8.6%	ratio	10-Q	2020-05-08
Quarterly	2019-06-30	0.1295	-4.0%	ratio	10-Q	2020-08-07
Quarterly	2019-12-31	0.1301	+0.5%	ratio	10-Q	2021-02-08
Quarterly	2020-03-31	0.0801	-38.5%	ratio	10-Q	2021-05-07
Quarterly	2020-06-30	0.0917	+14.5%	ratio	10-Q	2021-08-09
Quarterly	2020-12-31	0.1381	+50.6%	ratio	10-Q	2022-02-08
Quarterly	2021-03-31	0.1474	+6.7%	ratio	10-Q	2022-05-09
Quarterly	2021-06-30	0.1223	-17.0%	ratio	10-Q	2022-08-08
Quarterly	2021-12-31	0.1583	+29.5%	ratio	10-Q	2023-02-03
Quarterly	2022-03-31	0.1191	-24.7%	ratio	10-Q	2023-05-08
Quarterly	2022-06-30	0.1084	-9.1%	ratio	10-Q	2023-08-04
Quarterly	2022-12-31	0.1682	+55.2%	ratio	10-Q	2024-02-07
Quarterly	2023-03-31	0.1353	-19.6%	ratio	10-Q	2024-05-07
Quarterly	2023-06-30	0.1121	-17.2%	ratio	10-Q	2024-08-06
Quarterly	2023-12-31	0.1415	+26.3%	ratio	10-Q	2025-02-07
Quarterly	2024-03-31	0.1308	-7.5%	ratio	10-Q	2025-05-07
Quarterly	2024-06-30	0.1308	-0.0%	ratio	10-Q	2025-08-06
Quarterly	2024-12-31	0.1487	+13.7%	ratio	10-Q	2026-02-06
Quarterly	2025-03-31	0.1287	-13.4%	ratio	10-Q	2025-05-07
Quarterly	2025-06-30	0.1135	-11.9%	ratio	10-Q	2025-08-06
Quarterly	2025-12-31	0.1348	+18.8%	ratio	10-Q	2026-02-06
Annual	2016-09-30	0.0979	—	ratio	10-K	2018-11-21
Annual	2017-09-30	0.0975	-0.5%	ratio	10-K	2019-11-26
Annual	2018-09-30	0.1146	+17.6%	ratio	10-K	2020-11-24
Annual	2019-09-30	0.1289	+12.4%	ratio	10-K	2021-11-23
Annual	2020-09-30	0.1001	-22.3%	ratio	10-K	2022-11-22
Annual	2021-09-30	0.1416	+41.4%	ratio	10-K	2023-11-21
Annual	2022-09-30	0.1334	-5.7%	ratio	10-K	2024-11-26
Annual	2023-09-30	0.1339	+0.3%	ratio	10-K	2025-11-25
Annual	2024-09-30	0.1386	+3.5%	ratio	10-K	2025-11-25
Annual	2025-09-30	0.1342	-3.2%	ratio	10-K	2025-11-25

ROA

Profitability Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0044	—	ratio	10-Q	2017-05-10
Quarterly	2016-06-30	0.0046	+4.7%	ratio	10-Q	2017-08-08
Quarterly	2016-12-31	0.0047	+1.5%	ratio	10-Q	2018-02-08
Quarterly	2017-03-31	0.0033	-29.3%	ratio	10-Q	2018-05-09
Quarterly	2017-06-30	0.0055	+68.2%	ratio	10-Q	2018-08-07
Quarterly	2017-12-31	0.0033	-40.5%	ratio	10-Q	2019-02-08
Quarterly	2018-03-31	0.0067	+104.5%	ratio	10-Q	2019-05-09
Quarterly	2018-06-30	0.0064	-5.4%	ratio	10-Q	2019-08-08
Quarterly	2018-12-31	0.0065	+1.3%	ratio	10-Q	2020-02-07
Quarterly	2019-03-31	0.0068	+5.8%	ratio	10-Q	2020-05-08
Quarterly	2019-06-30	0.0067	-2.1%	ratio	10-Q	2020-08-07
Quarterly	2019-12-31	0.0067	-0.3%	ratio	10-Q	2021-02-08
Quarterly	2020-03-31	0.0034	-49.2%	ratio	10-Q	2021-05-07
Quarterly	2020-06-30	0.0038	+13.5%	ratio	10-Q	2021-08-09
Quarterly	2020-12-31	0.0058	+51.1%	ratio	10-Q	2022-02-08
Quarterly	2021-03-31	0.0063	+8.9%	ratio	10-Q	2022-05-09
Quarterly	2021-06-30	0.0054	-15.2%	ratio	10-Q	2022-08-08
Quarterly	2021-12-31	0.0065	+21.3%	ratio	10-Q	2023-02-03
Quarterly	2022-03-31	0.0044	-32.2%	ratio	10-Q	2023-05-08
Quarterly	2022-06-30	0.0035	-20.9%	ratio	10-Q	2023-08-04
Quarterly	2022-12-31	0.0066	+89.0%	ratio	10-Q	2024-02-07
Quarterly	2023-03-31	0.0054	-18.4%	ratio	10-Q	2024-05-07
Quarterly	2023-06-30	0.0048	-11.9%	ratio	10-Q	2024-08-06
Quarterly	2023-12-31	0.0062	+30.8%	ratio	10-Q	2025-02-07
Quarterly	2024-03-31	0.0059	-5.7%	ratio	10-Q	2025-05-07
Quarterly	2024-06-30	0.0061	+4.1%	ratio	10-Q	2025-08-06
Quarterly	2024-12-31	0.0073	+19.5%	ratio	10-Q	2026-02-06
Quarterly	2025-03-31	0.0060	-18.3%	ratio	10-Q	2025-05-07
Quarterly	2025-06-30	0.0051	-13.7%	ratio	10-Q	2025-08-06
Quarterly	2025-12-31	0.0063	+23.4%	ratio	10-Q	2026-02-06
Annual	2016-09-30	0.0172	—	ratio	10-K	2018-11-21
Annual	2017-09-30	0.0182	+6.2%	ratio	10-K	2019-11-26
Annual	2018-09-30	0.0229	+25.6%	ratio	10-K	2020-11-24
Annual	2019-09-30	0.0266	+16.3%	ratio	10-K	2021-11-23
Annual	2020-09-30	0.0172	-35.3%	ratio	10-K	2022-11-22
Annual	2021-09-30	0.0227	+31.6%	ratio	10-K	2023-11-21
Annual	2022-09-30	0.0186	-17.8%	ratio	10-K	2024-11-26
Annual	2023-09-30	0.0222	+19.1%	ratio	10-K	2025-11-25
Annual	2024-09-30	0.0249	+12.3%	ratio	10-K	2025-11-25
Annual	2025-09-30	0.0242	-2.9%	ratio	10-K	2025-11-25

ROE

Profitability Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0255	—	ratio	10-Q	2017-05-10
Quarterly	2016-06-30	0.0271	+6.3%	ratio	10-Q	2017-08-08
Quarterly	2016-12-31	0.0284	+4.8%	ratio	10-Q	2018-02-08
Quarterly	2017-03-31	0.0204	-28.2%	ratio	10-Q	2018-05-09
Quarterly	2017-06-30	0.0337	+65.4%	ratio	10-Q	2018-08-07
Quarterly	2017-12-31	0.0205	-39.1%	ratio	10-Q	2019-02-08
Quarterly	2018-03-31	0.0402	+96.1%	ratio	10-Q	2019-05-09
Quarterly	2018-06-30	0.0371	-7.7%	ratio	10-Q	2019-08-08
Quarterly	2018-12-31	0.0400	+7.8%	ratio	10-Q	2020-02-07
Quarterly	2019-03-31	0.0406	+1.4%	ratio	10-Q	2020-05-08
Quarterly	2019-06-30	0.0395	-2.7%	ratio	10-Q	2020-08-07
Quarterly	2019-12-31	0.0388	-1.6%	ratio	10-Q	2021-02-08
Quarterly	2020-03-31	0.0247	-36.3%	ratio	10-Q	2021-05-07
Quarterly	2020-06-30	0.0245	-0.9%	ratio	10-Q	2021-08-09
Quarterly	2020-12-31	0.0419	+71.1%	ratio	10-Q	2022-02-08
Quarterly	2021-03-31	0.0465	+10.8%	ratio	10-Q	2022-05-09
Quarterly	2021-06-30	0.0388	-16.6%	ratio	10-Q	2022-08-08
Quarterly	2021-12-31	0.0515	+33.0%	ratio	10-Q	2023-02-03
Quarterly	2022-03-31	0.0375	-27.2%	ratio	10-Q	2023-05-08
Quarterly	2022-06-30	0.0317	-15.5%	ratio	10-Q	2023-08-04
Quarterly	2022-12-31	0.0518	+63.3%	ratio	10-Q	2024-02-07
Quarterly	2023-03-31	0.0428	-17.3%	ratio	10-Q	2024-05-07
Quarterly	2023-06-30	0.0372	-13.2%	ratio	10-Q	2024-08-06
Quarterly	2023-12-31	0.0462	+24.2%	ratio	10-Q	2025-02-07
Quarterly	2024-03-31	0.0434	-6.1%	ratio	10-Q	2025-05-07
Quarterly	2024-06-30	0.0440	+1.4%	ratio	10-Q	2025-08-06
Quarterly	2024-12-31	0.0503	+14.4%	ratio	10-Q	2026-02-06
Quarterly	2025-03-31	0.0405	-19.5%	ratio	10-Q	2025-05-07
Quarterly	2025-06-30	0.0356	-12.2%	ratio	10-Q	2025-08-06
Quarterly	2025-12-31	0.0448	+25.9%	ratio	10-Q	2026-02-06
Annual	2016-09-30	0.1068	—	ratio	10-K	2018-11-21
Annual	2017-09-30	0.1117	+4.6%	ratio	10-K	2019-11-26
Annual	2018-09-30	0.1328	+18.9%	ratio	10-K	2020-11-24
Annual	2019-09-30	0.1557	+17.2%	ratio	10-K	2021-11-23
Annual	2020-09-30	0.1140	-26.8%	ratio	10-K	2022-11-22
Annual	2021-09-30	0.1690	+48.2%	ratio	10-K	2023-11-21
Annual	2022-09-30	0.1600	-5.3%	ratio	10-K	2024-11-26
Annual	2023-09-30	0.1707	+6.7%	ratio	10-K	2025-11-25
Annual	2024-09-30	0.1773	+3.8%	ratio	10-K	2025-11-25
Annual	2025-09-30	0.1707	-3.7%	ratio	10-K	2025-11-25

8-K Material Event Details

110 filings · 238 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

455 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-03-19	Allaire Bella Loykhter	Chief Admin Officer	Open-market sell S	Common Stock	29,551	$142.34	$4,206,289	53,586
2026-02-28	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	600
2026-02-28	Aisenbrey Christopher S	Chief Human Resources Officer	Other disposed transaction F	Common Stock	132	$153.08	$20,207	17,490
2026-02-28	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M	Common Stock	600	$0.00	$0	17,622
2026-02-24	Edwards Jeffrey N	Dir	Equity grant / award G	Common Stock	1,504	$0.00	$0	22,008
2026-02-19	Seshadri Raj	Dir	Equity grant / award A	Common Stock	1,303	$0.00	$0	13,782
2026-02-04	Santelli Jonathan N	EVP, General Counsel	Open-market sell S	Common Stock	4,500	$170.46	$767,079	26,853
2026-01-30	Edwards Jeffrey N	Dir	Equity grant / award G	Common Stock	20,504	$0.00	$0	20,504
2025-12-30	Helal Tarek	Chief Strategy Officer	Equity grant / award G	Common Stock	81	$0.00	$0	81
2025-12-30	Helal Tarek	Chief Strategy Officer	Equity grant / award G	Common Stock	80	$0.00	$0	81
2025-12-15	Elwyn Tashtego S	President, PCG	Equity grant / award A · derivative	Restricted Stock Units	6,103	$0.00	$0	6,103
2025-12-15	Elwyn Tashtego S	President, PCG	Exercise / conversion M · derivative	Restricted Stock Units	4,194	$0.00	$0	0
2025-12-15	Elwyn Tashtego S	President, PCG	Equity grant / award A · derivative	Restricted Stock Units	3,661	$0.00	$0	3,661
2025-12-15	Elwyn Tashtego S	President, PCG	Exercise / conversion M · derivative	Restricted Stock Units	27,203	$0.00	$0	20,312
2025-12-15	Elwyn Tashtego S	President, PCG	Exercise / conversion M · derivative	Restricted Stock Units	3,264	$0.00	$0	47,515
2025-12-15	Elwyn Tashtego S	President, PCG	Other disposed transaction F	Common Stock	10,704	$163.85	$1,753,850	55,114
2025-12-15	Elwyn Tashtego S	President, PCG	Other disposed transaction F	Common Stock	2,136	$163.85	$349,984	65,818
2025-12-15	Elwyn Tashtego S	President, PCG	Other disposed transaction F	Common Stock	1,651	$163.85	$270,516	67,954
2025-12-15	Elwyn Tashtego S	President, PCG	Other disposed transaction F	Common Stock	1,284	$163.85	$210,383	69,605
2025-12-15	Elwyn Tashtego S	President, PCG	Exercise / conversion M	Common Stock	3,264	$0.00	$0	70,889
2025-12-15	Elwyn Tashtego S	President, PCG	Exercise / conversion M	Common Stock	4,194	$0.00	$0	67,625
2025-12-15	Elwyn Tashtego S	President, PCG	Exercise / conversion M	Common Stock	27,203	$0.00	$0	63,431
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Equity grant / award A · derivative	Restricted Stock Units	1,488	$0.00	$0	1,488
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	1,644	$0.00	$0	0
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Equity grant / award A · derivative	Restricted Stock Units	3,661	$0.00	$0	3,661
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	3,264	$0.00	$0	3,989
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	2,720	$0.00	$0	7,253
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	1,284	$163.85	$210,383	31,353
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	1,070	$163.85	$175,320	32,637
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	837	$163.85	$137,142	33,707
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	647	$163.85	$106,011	34,544
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	1,644	$0.00	$0	35,191
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	2,720	$0.00	$0	33,547
2025-12-15	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	3,264	$0.00	$0	30,827
2025-12-12	Elwyn Tashtego S	President, PCG	Equity grant / award G	Common Stock	2,703	$0.00	$0	36,228
2025-12-10	Campagnoli Vincent	EVP, Technology & Operations	Equity grant / award G	Common Stock	60	$0.00	$0	32,685
2025-12-05	Larson Katherine H	Chief Accounting Officer	Equity grant / award A · derivative	Restricted Stock Units	323	$0.00	$0	323
2025-12-04	Curtis Scott A	Chief Operating Officer	Equity grant / award G	Common Stock	1,022	$0.00	$0	173,143
2025-12-04	Haynes Morgan Tarazeta J	Chief Audit Executive	Equity grant / award G	Common Stock	616	$0.00	$0	3,993
2025-12-02	Shoukry Paul M	CEO	Equity grant / award A	Common Stock	7,043	$0.00	$0	43,275
2025-11-30	Shoukry Paul M	CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,318	$0.00	$0	2,318
2025-11-30	Shoukry Paul M	CEO	Exercise / conversion M · derivative	Restricted Stock Units	1,500	$0.00	$0	0
2025-11-30	Shoukry Paul M	CEO	Other disposed transaction F	Common Stock	912	$156.54	$142,764	36,232
2025-11-30	Shoukry Paul M	CEO	Other disposed transaction F	Common Stock	590	$156.54	$92,359	37,144
2025-11-30	Shoukry Paul M	CEO	Exercise / conversion M	Common Stock	1,500	$0.00	$0	37,734
2025-11-30	Shoukry Paul M	CEO	Exercise / conversion M	Common Stock	2,318	$0.00	$0	36,234
2025-11-21	Larson Katherine H	Chief Accounting Officer	Equity grant / award A · derivative	Restricted Stock Units	1,652	$0.00	$0	1,652
2025-11-20	Raney Steven M	Executive Chair RJBank	Equity grant / award G	Common Stock	1,611	$0.00	$0	42,351
2025-11-05	Campagnoli Vincent	EVP, Technology & Operations	Equity grant / award G	Common Stock	949	$0.00	$0	26,287
2025-08-18	Haynes Morgan Tarazeta J	Chief Audit Executive	Equity grant / award G	Common Stock	114	$0.00	$0	3,631
2025-08-12	Santelli Jonathan N	EVP, Gen Counsel, Secy	Equity grant / award G	Common Stock	300	$0.00	$0	22,579
2025-05-29	Allaire Bella Loykhter	Chief Admin Officer	Open-market sell S	Common Stock	6,570	$146.61	$963,228	74,586
2025-05-21	Begor Mark W	Dir	Equity grant / award A	Common Stock	982	$0.00	$0	982
2025-05-20	Mistarz Cecily	Dir	Exercise / conversion M · derivative	Restricted Stock Units	1,186	$0.00	$0	0
2025-05-20	Mistarz Cecily	Dir	Exercise / conversion M	Common Stock	1,186	$0.00	$0	1,186
2025-05-19	Elwyn Tashtego S	President, PCG	Equity grant / award G	Common Stock	1,500	$0.00	$0	31,708
2025-04-28	Bunn James E	President, Capital Markets	Open-market sell S	Common Stock	3,650	$136.49	$498,184	78,227
2025-02-28	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,800	$0.00	$0	1,200
2025-02-28	Aisenbrey Christopher S	Chief Human Resources Officer	Other disposed transaction F	Common Stock	470	$151.73	$71,313	14,129
2025-02-28	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M	Common Stock	1,800	$0.00	$0	14,599
2025-02-20	Shoukry Paul M	CEO	Equity grant / award A · derivative	Restricted Stock Units	15,666	$0.00	$0	15,666
2025-01-31	Santelli Jonathan N	EVP, Gen Counsel, Secy	Open-market sell S	Common Stock	4,160	$168.25	$699,932	22,879
2025-01-02	REILLY PAUL C	Chair & CEO	Other disposed transaction F	Common Stock	26,748	$155.33	$4,154,767	256,363
2024-12-15	Shoukry Paul M	President	Exercise / conversion M · derivative	Restricted Stock Units	4,409	$0.00	$0	0
2024-12-15	Shoukry Paul M	President	Other disposed transaction F	Common Stock	1,734	$160.49	$278,290	35,949
2024-12-15	Shoukry Paul M	President	Exercise / conversion M	Common Stock	4,409	$0.00	$0	37,683
2024-12-13	Shoukry Paul M	President	Equity grant / award A · derivative	Restricted Stock Units	7,950	$0.00	$0	7,950
2024-12-13	Shoukry Paul M	President	Equity grant / award A · derivative	Restricted Stock Units	6,235	$0.00	$0	6,235
2024-12-13	Reid Shannon B	President, ICD	Equity grant / award A · derivative	Restricted Stock Units	265	$0.00	$0	265
2024-12-13	Reid Shannon B	President, ICD	Equity grant / award A · derivative	Restricted Stock Units	3,741	$0.00	$0	3,741
2024-12-12	Shoukry Paul M	President	Exercise / conversion M · derivative	Restricted Stock Units	900	$0.00	$0	0
2024-12-12	Shoukry Paul M	President	Other disposed transaction F	Common Stock	354	$161.51	$57,175	33,274
2024-12-12	Shoukry Paul M	President	Exercise / conversion M	Common Stock	900	$0.00	$0	33,628
2024-12-11	REILLY PAUL C	Chair & CEO	Equity grant / award G	Common Stock	18,559	$0.00	$0	264,551
2024-12-10	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M · derivative	Restricted Stock Units	488	$0.00	$0	0
2024-12-10	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M	Common Stock	488	$0.00	$0	18,463
2024-12-09	Elwyn Tashtego S	President, PCG	Equity grant / award G	Common Stock	325	$0.00	$0	42,688
2024-12-06	Krauss David	Chief Risk Officer	Equity grant / award A · derivative	Restricted Stock Units	679	$0.00	$0	679
2024-12-05	Santelli Jonathan N	EVP, Gen Counsel, Secy	Open-market sell S	Common Stock	3,100	$165.59	$513,318	26,845
2024-12-04	Reid Shannon B	President, ICD	Open-market sell S	Common Stock	1,241	$165.30	$205,141	7,079
2024-12-04	Reid Shannon B	President, ICD	Equity grant / award G	Common Stock	315	$0.00	$0	8,320
2024-12-03	Elwyn Tashtego S	President, PCG	Equity grant / award G	Common Stock	225	$0.00	$0	43,013
2024-12-02	REILLY PAUL C	Chair & CEO	Open-market sell S	Common Stock	50,000	$167.30	$8,365,065	283,110
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	3,793	$0.00	$0	4,550
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	3,032	$0.00	$0	8,343
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	1,500	$0.00	$0	1,500
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	1,298	$169.28	$219,725	29,945
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	1,037	$169.28	$175,543	31,243
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	513	$169.28	$86,841	32,280
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	1,500	$0.00	$0	32,793
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	3,032	$0.00	$0	31,293
2024-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	3,793	$0.00	$0	28,261
2024-11-30	REILLY PAUL C	Chair & CEO	Exercise / conversion M · derivative	Restricted Stock Units	8,218	$0.00	$0	5,479
2024-11-30	REILLY PAUL C	Chair & CEO	Exercise / conversion M · derivative	Restricted Stock Units	3,900	$0.00	$0	3,900
2024-11-30	REILLY PAUL C	Chair & CEO	Other disposed transaction F	Common Stock	3,040	$169.28	$514,611	333,110
2024-11-30	REILLY PAUL C	Chair & CEO	Other disposed transaction F	Common Stock	1,443	$169.28	$244,271	336,150
2024-11-30	REILLY PAUL C	Chair & CEO	Exercise / conversion M	Common Stock	3,900	$0.00	$0	337,593
2024-11-30	REILLY PAUL C	Chair & CEO	Exercise / conversion M	Common Stock	8,218	$0.00	$0	333,693
2024-11-29	Santelli Jonathan N	EVP, Gen Counsel, Secy	Equity grant / award G	Common Stock	355	$0.00	$0	24,468
2024-11-25	Curtis Scott A	Chief Operating Officer	Equity grant / award A	Common Stock	5,275	$0.00	$0	184,899
2024-11-25	Krauss David	Chief Risk Officer	Equity grant / award A · derivative	Restricted Stock Units	2,421	$0.00	$0	2,421
2024-11-22	Curtis Scott A	Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,500	$0.00	$0	0
2024-11-22	Curtis Scott A	Chief Operating Officer	Other disposed transaction F	Common Stock	330	$163.78	$54,047	179,624
2024-11-22	Curtis Scott A	Chief Operating Officer	Exercise / conversion M	Common Stock	1,500	$0.00	$0	179,954
2024-09-30	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M · derivative	Restricted Stock Units	2,058	$0.00	$0	0
2024-09-30	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M	Common Stock	2,058	$0.00	$0	17,975
2024-09-04	Curtis Scott A	President, PCG	Equity grant / award G	Common Stock	1,000	$0.00	$0	178,454
2024-08-12	Elwyn Tashtego S	CEO & President - RJA	Open-market sell S	Common Stock	31,277	$109.64	$3,429,263	35,380
2024-07-31	Allaire Bella Loykhter	Executive Vice President-RJA	Open-market sell S	Common Stock	17,363	$115.00	$1,996,684	75,586
2024-05-20	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Equity grant / award A · derivative	Restricted Stock Units	19,775	$0.00	$0	19,775
2024-05-03	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Open-market sell S	Common Stock	11,095	$124.44	$1,380,614	46,977
2024-04-29	Allaire Bella Loykhter	Executive Vice President-RJA	Equity grant / award G	Common Stock	100	$0.00	$0	92,949
2024-04-26	Raney Steven M	President & CEO RJBank	Open-market sell S	Common Stock	4,174	$121.01	$505,107	51,009
2024-04-10	MCDANIEL RAYMOND W	Dir	Exercise / conversion M · derivative	Restricted Stock Units	1,846	$0.00	$0	0
2024-04-10	MCDANIEL RAYMOND W	Dir	Exercise / conversion M	Common Stock	1,846	$0.00	$0	1,846
2024-03-05	Reid Shannon B	President, ICD for RJFS	Equity grant / award G	Common Stock	10	$0.00	$0	7,316
2024-02-22	GARCIA ART A	Dir	Equity grant / award A · derivative	Restricted Stock Units	1,711	$0.00	$0	1,711
2024-02-09	GARCIA ART A	Dir	Open-market buy P	Common Stock	879	$112.30	$98,715	879
2024-01-29	Santelli Jonathan N	EVP, Gen Counsel, Secy	Open-market sell S	Common Stock	973	$111.98	$108,957	21,491
2024-01-29	Santelli Jonathan N	EVP, Gen Counsel, Secy	Open-market sell S	Common Stock	918	$111.84	$102,669	22,464
2024-01-02	REILLY PAUL C	Chair & CEO	Other disposed transaction F	Common Stock	24,323	$111.50	$2,712,014	248,208
2023-12-15	REILLY PAUL C	Chair & CEO	Equity grant / award A · derivative	Restricted Stock Units	33,369	$0.00	$0	33,369
2023-12-15	REILLY PAUL C	Chair & CEO	Exercise / conversion M · derivative	Restricted Stock Units	30,833	$0.00	$0	0
2023-12-15	REILLY PAUL C	Chair & CEO	Equity grant / award A · derivative	Restricted Stock Units	11,724	$0.00	$0	11,724
2023-12-15	REILLY PAUL C	Chair & CEO	Other disposed transaction F	Common Stock	11,408	$110.88	$1,264,919	272,531
2023-12-15	REILLY PAUL C	Chair & CEO	Exercise / conversion M	Common Stock	30,833	$0.00	$0	283,939
2023-12-15	Allaire Bella Loykhter	Executive Vice President-RJA	Equity grant / award A · derivative	Restricted Stock Units	3,946	$0.00	$0	3,946
2023-12-15	Allaire Bella Loykhter	Executive Vice President-RJA	Exercise / conversion M · derivative	Restricted Stock Units	3,177	$0.00	$0	0
2023-12-15	Allaire Bella Loykhter	Executive Vice President-RJA	Equity grant / award A · derivative	Restricted Stock Units	5,411	$0.00	$0	5,411
2023-12-15	Allaire Bella Loykhter	Executive Vice President-RJA	Other disposed transaction F	Common Stock	1,175	$110.88	$130,284	94,097
2023-12-15	Allaire Bella Loykhter	Executive Vice President-RJA	Exercise / conversion M	Common Stock	3,177	$0.00	$0	95,272
2023-12-14	REILLY PAUL C	Chair & CEO	Equity grant / award G	Common Stock	19,116	$0.00	$0	253,106
2023-12-13	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	1,165	$0.00	$0	67,262
2023-12-12	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	737	$0.00	$0	68,427
2023-12-11	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M · derivative	Restricted Stock Units	407	$0.00	$0	0
2023-12-11	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M	Common Stock	407	$0.00	$0	15,917
2023-12-04	Raney Steven M	President & CEO RJBank	Equity grant / award G	Common Stock	1,404	$0.00	$0	55,560
2023-12-01	Oorlog Jonathan W JR	SVP & Chief Accounting Officer	Equity grant / award A · derivative	Restricted Stock Units	782	$0.00	$0	782
2023-11-30	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Exercise / conversion M · derivative	Restricted Stock Units	4,500	$0.00	$0	3,000
2023-11-30	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Other disposed transaction F	Common Stock	1,497	$103.75	$155,314	49,765
2023-11-30	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Exercise / conversion M	Common Stock	4,500	$0.00	$0	51,262
2023-11-30	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M · derivative	Restricted Stock Units	2,700	$0.00	$0	1,800
2023-11-30	Aisenbrey Christopher S	Chief Human Resources Officer	Other disposed transaction F	Common Stock	657	$103.75	$68,164	8,984
2023-11-30	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M	Common Stock	2,700	$0.00	$0	9,641
2023-11-29	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Exercise / conversion M · derivative	Restricted Stock Units	1,500	$0.00	$0	0
2023-11-29	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Other disposed transaction F	Common Stock	330	$102.73	$33,901	46,762
2023-11-29	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Exercise / conversion M	Common Stock	1,500	$0.00	$0	47,092
2023-11-29	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M · derivative	Restricted Stock Units	450	$0.00	$0	0
2023-11-29	Aisenbrey Christopher S	Chief Human Resources Officer	Other disposed transaction F	Common Stock	109	$102.73	$11,198	6,941
2023-11-29	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M	Common Stock	450	$0.00	$0	7,050
2023-11-22	Raney Steven M	President & CEO RJBank	Exercise / conversion M · derivative	Restricted Stock Units	1,500	$0.00	$0	1,500
2023-11-22	Raney Steven M	President & CEO RJBank	Other disposed transaction F	Common Stock	330	$104.27	$34,409	55,920
2023-11-22	Raney Steven M	President & CEO RJBank	Exercise / conversion M	Common Stock	1,500	$0.00	$0	56,250
2023-11-20	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Equity grant / award A	Common Stock	4,152	$0.00	$0	44,422
2023-11-08	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Open-market sell S	Common Stock	8,044	$99.41	$799,629	40,270
2023-11-03	Shoukry Paul M	Chief Financial Officer	Equity grant / award G	Common Stock	1,000	$0.00	$0	15,700
2023-09-30	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M · derivative	Restricted Stock Units	3,203	$0.00	$0	0
2023-09-30	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M	Common Stock	3,203	$0.00	$0	15,510
2023-08-01	Santelli Jonathan N	EVP, Gen Counsel, Secy	Equity grant / award G	Common Stock	500	$0.00	$0	15,820
2023-07-31	Carter Horace	President, Fixed Income	Open-market sell S	Common Stock	3,753	$109.12	$409,527	19,515
2023-06-12	Carter Horace	President, Fixed Income	Equity grant / award G	Common Stock	105	$0.00	$0	23,268
2023-06-07	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Open-market sell S	Common Stock	5,281	$96.36	$508,884	48,314
2023-04-10	MCDANIEL RAYMOND W	Dir	Equity grant / award A · derivative	Restricted Stock Units	1,846	$0.00	$0	1,846
2023-02-23	Seshadri Raj	Dir	Exercise / conversion M · derivative	Restricted Stock Units	1,683	$0.00	$0	1,643
2023-02-23	Seshadri Raj	Dir	Equity grant / award A · derivative	Restricted Stock Units	1,643	$0.00	$0	3,326
2023-02-23	Seshadri Raj	Dir	Exercise / conversion M	Common Stock	1,683	$0.00	$0	7,872
2023-02-06	Perry Jodi	President, ICD for RJFS	Open-market sell S	Common Stock	6,343	$112.30	$712,319	7,150
2023-01-03	Curtis Scott A	President, PCG	Other disposed transaction F	Common Stock	1,039	$106.11	$110,248	169,091
2022-12-28	Curtis Scott A	President, PCG	Equity grant / award G	Common Stock	500	$0.00	$0	170,130
2022-12-15	REILLY PAUL C	Chair & CEO	Equity grant / award A · derivative	Restricted Stock Units	54,406	$0.00	$0	54,406
2022-12-15	REILLY PAUL C	Chair & CEO	Equity grant / award A · derivative	Restricted Stock Units	30,853	$0.00	$0	30,853
2022-12-15	REILLY PAUL C	Chair & CEO	Equity grant / award A · derivative	Restricted Stock Units	11,788	$0.00	$0	11,788
2022-12-14	REILLY PAUL C	Chair & CEO	Open-market sell S	Common Stock	24,016	$111.27	$2,672,330	267,499
2022-12-13	Perry Jodi	President, ICD for RJFS	Exercise / conversion M · derivative	Restricted Stock Units	453	$0.00	$0	0
2022-12-13	Perry Jodi	President, ICD for RJFS	Other disposed transaction F	Common Stock	178	$111.52	$19,851	13,669
2022-12-13	Perry Jodi	President, ICD for RJFS	Exercise / conversion M	Common Stock	453	$0.00	$0	13,847
2022-12-13	REILLY PAUL C	Chair & CEO	Exercise / conversion M · derivative	Restricted Stock Units	38,736	$0.00	$0	0
2022-12-13	REILLY PAUL C	Chair & CEO	Other disposed transaction F	Common Stock	14,332	$111.52	$1,598,305	291,515
2022-12-13	REILLY PAUL C	Chair & CEO	Exercise / conversion M	Common Stock	38,736	$0.00	$0	305,847
2022-12-12	Perry Jodi	President, ICD for RJFS	Exercise / conversion M · derivative	Restricted Stock Units	2,700	$0.00	$0	1,800
2022-12-12	Perry Jodi	President, ICD for RJFS	Other disposed transaction F	Common Stock	1,062	$114.58	$121,684	13,394
2022-12-12	Perry Jodi	President, ICD for RJFS	Exercise / conversion M	Common Stock	2,700	$0.00	$0	14,456
2022-12-08	Catanese George	Chief Risk Officer	Equity grant / award G	Common Stock	135	$0.00	$0	11,727
2022-12-08	Catanese George	Chief Risk Officer	Open-market sell S	Common Stock	3,489	$114.02	$397,829	11,862
2022-12-02	Oorlog Jonathan W JR	Senior VP and Controller	Equity grant / award A · derivative	Restricted Stock Units	631	$0.00	$0	631
2022-11-30	REILLY PAUL C	Chair & CEO	Exercise / conversion M · derivative	Restricted Stock Units	3,750	$0.00	$0	0
2022-11-30	REILLY PAUL C	Chair & CEO	Other disposed transaction F	Common Stock	1,475	$116.90	$172,428	267,111
2022-11-30	REILLY PAUL C	Chair & CEO	Exercise / conversion M	Common Stock	3,750	$0.00	$0	268,586
2022-11-30	REILLY PAUL C	Chair & CEO	Equity grant / award A	Common Stock	76,117	$0.00	$0	264,836
2022-11-30	JAMES THOMAS A	Chairman Emeritus	Equity grant / award A	Common Stock	1,080	$0.00	$0	17,603,780
2022-11-29	REILLY PAUL C	Chair & CEO	Exercise / conversion M · derivative	Restricted Stock Units	3,750	$0.00	$0	3,750
2022-11-29	REILLY PAUL C	Chair & CEO	Other disposed transaction F	Common Stock	1,387	$115.37	$160,018	188,719
2022-11-29	REILLY PAUL C	Chair & CEO	Exercise / conversion M	Common Stock	3,750	$0.00	$0	190,106
2022-11-22	Oorlog Jonathan W JR	Senior VP and Controller	Exercise / conversion M · derivative	Restricted Stock Units	1,800	$0.00	$0	1,200
2022-11-22	Oorlog Jonathan W JR	Senior VP and Controller	Exercise / conversion M · derivative	Restricted Stock Units	450	$0.00	$0	0
2022-11-22	Oorlog Jonathan W JR	Senior VP and Controller	Other disposed transaction F	Common Stock	414	$123.52	$51,137	12,995
2022-11-22	Oorlog Jonathan W JR	Senior VP and Controller	Other disposed transaction F	Common Stock	103	$123.52	$12,723	13,409
2022-11-22	Oorlog Jonathan W JR	Senior VP and Controller	Exercise / conversion M	Common Stock	450	$0.00	$0	13,512
2022-11-22	Oorlog Jonathan W JR	Senior VP and Controller	Exercise / conversion M	Common Stock	1,800	$0.00	$0	13,062
2022-11-22	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M · derivative	Restricted Stock Units	2,700	$0.00	$0	1,800
2022-11-22	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M · derivative	Restricted Stock Units	360	$0.00	$0	0
2022-11-22	Aisenbrey Christopher S	Chief Human Resources Officer	Other disposed transaction F	Common Stock	657	$123.52	$81,153	5,467
2022-11-22	Aisenbrey Christopher S	Chief Human Resources Officer	Other disposed transaction F	Common Stock	87	$123.52	$10,746	6,124
2022-11-22	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M	Common Stock	360	$0.00	$0	6,211
2022-11-22	Aisenbrey Christopher S	Chief Human Resources Officer	Exercise / conversion M	Common Stock	2,700	$0.00	$0	5,851
2022-11-21	Oorlog Jonathan W JR	Senior VP and Controller	Equity grant / award A · derivative	Restricted Stock Units	2,056	$0.00	$0	2,056
2022-11-15	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	1,350	$123.80	$167,131	0
2022-10-31	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	1,332	$0.00	$0	50,616
2022-10-26	Catanese George	Chief Risk Officer	Equity grant / award G	Common Stock	45	$0.00	$0	10,514
2022-10-15	Carter Horace	President, Fixed Income	Exercise / conversion M · derivative	Restricted Stock Units	591	$0.00	$0	0
2022-10-15	Carter Horace	President, Fixed Income	Exercise / conversion M	Common Stock	591	$0.00	$0	19,764
2022-10-11	Allaire Bella Loykhter	Executive Vice President-RJA	Equity grant / award G	Common Stock	100	$0.00	$0	70,257
2022-09-30	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M · derivative	Restricted Stock Units	2,250	$0.00	$0	0
2022-09-30	Coulter James Robert Edward	Director & CEO, RJ Ltd.	Exercise / conversion M	Common Stock	2,250	$0.00	$0	12,307
2022-09-08	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Open-market sell S	Common Stock	4,000	$106.75	$427,004	21,096
2022-08-24	Johnson Gordon L	Dir	Equity grant / award A · derivative	Restricted Stock Units	164	$0.00	$0	2,174
2022-08-05	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	300	$0.00	$0	51,948
2022-07-15	Carter Horace	President, Fixed Income	Exercise / conversion M · derivative	Restricted Stock Units	446	$0.00	$0	0
2022-07-15	Carter Horace	President, Fixed Income	Exercise / conversion M	Common Stock	446	$0.00	$0	19,173
2022-06-24	Shoukry Paul M	CFO and Treasurer	Equity grant / award G	Common Stock	1,000	$0.00	$0	10,606
2022-05-15	Carter Horace	President, Fixed Income	Exercise / conversion M · derivative	Restricted Stock Units	150	$0.00	$0	0
2022-05-15	Carter Horace	President, Fixed Income	Exercise / conversion M	Common Stock	150	$0.00	$0	18,727
2022-05-03	JAMES THOMAS A	Chairman Emeritus	Other disposed transaction J	Common Stock	664,131	$0.00	$0	0
2022-04-15	Carter Horace	President, Fixed Income	Exercise / conversion M · derivative	Restricted Stock Units	144	$0.00	$0	0
2022-04-15	Carter Horace	President, Fixed Income	Exercise / conversion M	Common Stock	144	$0.00	$0	18,577
2022-02-25	Aisenbrey Christopher S	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Stock Units	3,000	$0.00	$0	3,000
2022-02-24	MCGEARY RODERICK C	Dir	Exercise / conversion M · derivative	Restricted Stock Units	1,925	$0.00	$0	1,683
2022-02-24	MCGEARY RODERICK C	Dir	Equity grant / award A · derivative	Restricted Stock Units	1,683	$0.00	$0	3,608
2022-02-24	MCGEARY RODERICK C	Dir	Exercise / conversion M	Common Stock	1,925	$0.00	$0	16,761
2022-02-17	Johnson Gordon L	Dir	Exercise / conversion M · derivative	Restricted Stock Units	90	$0.00	$0	0
2022-02-17	Johnson Gordon L	Dir	Exercise / conversion M	Common Stock	90	$0.00	$0	33,939
2022-02-10	Allaire Bella Loykhter	Executive Vice President-RJA	Open-market sell S	Common Stock	15,000	$114.78	$1,721,700	70,357
2022-02-07	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Open-market sell S	Common Stock	18,972	$112.73	$2,138,668	43,437
2022-02-01	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	1,801	$0.00	$0	52,248
2022-01-03	REILLY PAUL C	Chairman & CEO	Other disposed transaction F	Common Stock	29,317	$102.86	$3,015,547	179,268
2021-12-28	GODBOLD FRANCIS S	Vice Chairman	Equity grant / award G	Common Stock	4,750	$0.00	$0	197,000
2021-12-20	REILLY PAUL C	Chairman & CEO	Equity grant / award G	Common Stock	8,050	$0.00	$0	208,585
2021-12-17	Santelli Jonathan N	EVP, Gen Counsel, Secy	Equity grant / award A · derivative	Restricted Stock Units	5,054	$0.00	$0	11,375
2021-12-15	REILLY PAUL C	Chairman & CEO	Equity grant / award A · derivative	Restricted Stock Units	29,460	$0.00	$0	29,460
2021-12-14	REILLY PAUL C	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Units	43,662	$0.00	$0	0
2021-12-14	REILLY PAUL C	Chairman & CEO	Other disposed transaction F	Common Stock	16,154	$96.40	$1,557,246	216,635
2021-12-14	REILLY PAUL C	Chairman & CEO	Exercise / conversion M	Common Stock	43,662	$0.00	$0	232,789
2021-12-03	Oorlog Jonathan W JR	Senior VP and Controller	Equity grant / award A · derivative	Restricted Stock Units	139	$0.00	$0	139
2021-12-02	Perry Jodi	President, ICD for RJFS	Equity grant / award A · derivative	Restricted Stock Units	6,321	$0.00	$0	6,321
2021-12-01	REILLY PAUL C	Chairman & CEO	Equity grant / award A	Common Stock	83,177	$0.00	$0	189,127
2021-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	1,500	$0.00	$0	1,500
2021-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	582	$98.29	$57,205	10,227
2021-11-30	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	1,500	$0.00	$0	11,391
2021-11-29	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	4,500	$0.00	$0	3,000
2021-11-29	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	1,095	$100.57	$110,124	8,391
2021-11-29	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	4,500	$0.00	$0	9,486
2021-11-22	Shoukry Paul M	CFO and Treasurer	Exercise / conversion M · derivative	Restricted Stock Units	900	$0.00	$0	900
2021-11-22	Shoukry Paul M	CFO and Treasurer	Other disposed transaction F	Common Stock	219	$98.64	$21,602	9,447
2021-11-22	Shoukry Paul M	CFO and Treasurer	Exercise / conversion M	Common Stock	900	$0.00	$0	9,666
2021-11-16	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	1,900	$0.00	$0	43,268
2021-11-12	Allaire Bella Loykhter	Executive Vice President-RJA	Equity grant / award G	Common Stock	100	$0.00	$0	72,200
2021-11-11	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Open-market sell S	Common Stock	15,166	$100.73	$1,527,739	17,615
2021-09-30	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M · derivative	Restricted Stock Units	7,500	$0.00	$0	0
2021-09-30	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M	Common Stock	7,500	$0.00	$0	35,419
2021-09-07	Curtis Scott A	President, PCG	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	5,334	$0.00	$0	0
2021-09-07	Curtis Scott A	President, PCG	Exercise / conversion M	Common Stock	5,334	$55.49	$295,984	98,673
2021-07-16	Curtis Scott A	President, PCG	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	5,300	$0.00	$0	5,334
2021-07-16	Curtis Scott A	President, PCG	Exercise / conversion M	Common Stock	5,300	$55.49	$294,097	93,339
2021-05-26	Santelli Jonathan N	EVP, Gen Counsel, Secy	Open-market sell S	Common Stock	2,272	$133.03	$302,236	3,324
2021-05-25	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	3,000	$0.00	$0	0
2021-05-25	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	728	$131.79	$95,943	5,596
2021-05-25	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	3,000	$0.00	$0	6,324
2021-05-24	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	75	$0.00	$0	30,112
2021-05-20	Perry Jodi	President, ICD for RJFS	Open-market sell S	Common Stock	1,850	$132.94	$245,939	1,355
2021-05-10	Raney Steven M	President & CEO RJBank	Open-market sell S	Common Stock	1,630	$135.74	$221,254	32,900
2021-05-10	Raney Steven M	President & CEO RJBank	Open-market sell S	Common Stock	370	$136.07	$50,344	34,530
2021-05-03	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	380	$0.00	$0	30,187
2021-04-09	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Equity grant / award G	Common Stock	252	$0.00	$0	19,854
2021-03-29	Allaire Bella Loykhter	Executive Vice President-RJA	Open-market sell S	Common Stock	9,330	$123.59	$1,153,095	48,200
2021-03-11	Curtis Scott A	President, PCG	Open-market sell S	Common Stock	10,000	$118.09	$1,180,884	88,039
2021-03-03	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Open-market sell S	Common Stock	750	$119.10	$89,325	750
2021-03-03	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Open-market sell S	Common Stock	9,596	$118.72	$1,139,202	33,525
2021-02-24	GODBOLD FRANCIS S	Vice Chairman	Open-market sell S	Common Stock	25,042	$121.52	$3,043,146	134,500
2021-02-23	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	1,000	$0.00	$0	30,567
2021-02-22	Allison Paul D	Chair, President & CEO RJ Ltd.	Open-market sell S	Common Stock	10,000	$117.99	$1,179,875	13,950
2021-02-19	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	192,392	$116.62	$22,435,966	442,754
2021-02-19	Johnson Gordon L	Dir	Exercise / conversion M · derivative	Restricted Stock Units	60	$0.00	$0	0
2021-02-19	Johnson Gordon L	Dir	Equity grant / award A · derivative	Restricted Stock Units	215	$0.00	$0	1,498
2021-02-19	Johnson Gordon L	Dir	Exercise / conversion M	Common Stock	60	$0.00	$0	22,566
2021-02-18	Johnson Gordon L	Dir	Exercise / conversion M · derivative	Restricted Stock Units	1,727	$0.00	$0	1,283
2021-02-18	Johnson Gordon L	Dir	Equity grant / award A · derivative	Restricted Stock Units	1,283	$0.00	$0	3,010
2021-02-18	Johnson Gordon L	Dir	Exercise / conversion M	Common Stock	1,727	$0.00	$0	22,506
2021-02-18	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	27,608	$116.58	$3,218,577	635,146
2021-02-17	Johnson Gordon L	Dir	Exercise / conversion M · derivative	Restricted Stock Units	60	$0.00	$0	60
2021-02-17	Johnson Gordon L	Dir	Exercise / conversion M	Common Stock	60	$0.00	$0	20,779
2021-02-11	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	48,018	$112.94	$5,423,311	11,726,874
2021-02-09	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	116,883	$111.13	$12,989,442	11,774,892
2021-02-09	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	3,721	$111.75	$415,812	11,891,775
2021-02-08	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	81,378	$110.26	$8,972,966	11,895,496
2021-02-01	Allison Paul D	Chair, President & CEO RJ Ltd.	Open-market sell S	Common Stock	7,000	$100.95	$706,660	18,613
2021-01-29	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	12,500	$0.00	$0	0
2021-01-29	Allison Paul D	Chair, President & CEO RJ Ltd.	Other disposed transaction F	Common Stock	6,941	$99.93	$693,614	25,613
2021-01-29	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M	Common Stock	12,500	$55.49	$693,625	32,554
2021-01-04	REILLY PAUL C	Chairman & CEO	Other disposed transaction F	Common Stock	8,547	$94.03	$803,674	77,321
2020-12-15	REILLY PAUL C	Chairman & CEO	Equity grant / award A · derivative	Restricted Stock Units	20,555	$0.00	$0	20,555
2020-12-15	REILLY PAUL C	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Units	21,930	$0.00	$0	0
2020-12-15	REILLY PAUL C	Chairman & CEO	Other disposed transaction F	Common Stock	8,114	$93.49	$758,578	85,868
2020-12-15	REILLY PAUL C	Chairman & CEO	Exercise / conversion M	Common Stock	21,930	$0.00	$0	93,982
2020-12-15	JAMES THOMAS A	Chairman Emeritus	Equity grant / award A · derivative	Restricted Stock Units	547	$0.00	$0	547
2020-12-15	JAMES THOMAS A	Chairman Emeritus	Exercise / conversion M · derivative	Restricted Stock Units	3,174	$0.00	$0	0
2020-12-15	JAMES THOMAS A	Chairman Emeritus	Exercise / conversion M	Common Stock	3,174	$0.00	$0	11,976,874
2020-12-14	REILLY PAUL C	Chairman & CEO	Open-market sell S	Common Stock	13,816	$92.84	$1,282,684	72,052
2020-12-09	Allaire Bella Loykhter	Executive Vice President-RJA	Open-market sell S	Common Stock	1,546	$92.20	$142,536	56,761
2020-12-09	Allaire Bella Loykhter	Executive Vice President-RJA	Open-market sell S	Common Stock	1,413	$92.23	$130,327	58,307
2020-12-09	Allaire Bella Loykhter	Executive Vice President-RJA	Open-market sell S	Common Stock	1,219	$92.27	$112,480	59,720
2020-12-09	Allaire Bella Loykhter	Executive Vice President-RJA	Open-market sell S	Common Stock	1,135	$92.24	$104,687	60,939
2020-12-04	Catanese George	Chief Risk Officer	Equity grant / award G	Common Stock	150	$0.00	$0	3,160
2020-12-04	Catanese George	Chief Risk Officer	Open-market sell S	Common Stock	2,320	$96.49	$223,865	3,310
2020-12-04	Catanese George	Chief Risk Officer	Open-market sell S	Common Stock	1,385	$96.33	$133,416	5,630
2020-12-04	Catanese George	Chief Risk Officer	Open-market sell S	Common Stock	651	$96.57	$62,867	7,015
2020-12-04	Catanese George	Chief Risk Officer	Open-market sell S	Common Stock	308	$96.30	$29,661	7,666
2020-12-04	Catanese George	Chief Risk Officer	Open-market sell S	Common Stock	227	$96.57	$21,922	7,974
2020-12-04	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	12,500	$0.00	$0	0
2020-12-04	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Other disposed transaction F	Common Stock	9,009	$95.83	$863,332	42,480
2020-12-04	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Exercise / conversion M	Common Stock	12,500	$55.49	$693,625	51,489
2020-12-03	Catanese George	Chief Risk Officer	Equity grant / award A · derivative	Restricted Stock Units	3,000	$0.00	$0	3,000
2020-12-02	JAMES THOMAS A	Chairman Emeritus	Equity grant / award A	Common Stock	3,968	$0.00	$0	11,973,700
2020-11-30	REILLY PAUL C	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Units	7,500	$0.00	$0	5,000
2020-11-30	REILLY PAUL C	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Units	2,000	$0.00	$0	2,000
2020-11-30	REILLY PAUL C	Chairman & CEO	Other disposed transaction F	Common Stock	2,858	$90.95	$259,935	98,868
2020-11-30	REILLY PAUL C	Chairman & CEO	Other disposed transaction F	Common Stock	762	$90.95	$69,304	101,726
2020-11-30	REILLY PAUL C	Chairman & CEO	Exercise / conversion M	Common Stock	2,000	$0.00	$0	102,488
2020-11-30	REILLY PAUL C	Chairman & CEO	Exercise / conversion M	Common Stock	7,500	$0.00	$0	100,488
2020-11-22	Perry Jodi	President, ICD for RJFS	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	400
2020-11-22	Perry Jodi	President, ICD for RJFS	Other disposed transaction F	Common Stock	146	$88.51	$12,922	4,038
2020-11-22	Perry Jodi	President, ICD for RJFS	Exercise / conversion M	Common Stock	600	$0.00	$0	4,184
2020-11-19	Shoukry Paul M	CFO and Treasurer	Exercise / conversion M · derivative	Restricted Stock Units	600	$0.00	$0	0
2020-11-19	Shoukry Paul M	CFO and Treasurer	Other disposed transaction F	Common Stock	145	$89.20	$12,934	3,969
2020-11-19	Shoukry Paul M	CFO and Treasurer	Exercise / conversion M	Common Stock	600	$0.00	$0	4,114
2020-11-18	Allaire Bella Loykhter	Executive Vice President-RJA	Exercise / conversion M · derivative	Restricted Stock Units	1,500	$0.00	$0	0
2020-11-18	Allaire Bella Loykhter	Executive Vice President-RJA	Other disposed transaction F	Common Stock	365	$89.08	$32,514	55,992
2020-11-18	Allaire Bella Loykhter	Executive Vice President-RJA	Exercise / conversion M	Common Stock	1,500	$0.00	$0	56,357
2020-11-17	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Open-market sell S	Common Stock	9,200	$88.29	$812,307	33,124
2020-11-10	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	52,552	$85.92	$4,515,336	11,969,732
2020-11-09	JAMES THOMAS A	Chairman Emeritus	Open-market sell S	Common Stock	47,448	$86.74	$4,115,454	12,022,284
2020-11-04	Allison Paul D	Chair, President & CEO RJ Ltd.	Open-market sell S	Common Stock	1,550	$77.97	$120,846	23,950
2020-11-04	Allison Paul D	Chair, President & CEO RJ Ltd.	Open-market sell S	Common Stock	4,150	$78.07	$323,992	17,231
2020-11-03	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	12,500	$0.00	$0	0
2020-11-03	Allison Paul D	Chair, President & CEO RJ Ltd.	Other disposed transaction F	Common Stock	7,533	$79.98	$602,489	21,381
2020-11-03	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M	Common Stock	12,500	$48.20	$602,500	28,914
2020-11-02	Allaire Bella Loykhter	Executive Vice President-RJA	Open-market sell S	Common Stock	3,178	$77.91	$247,587	54,857
2020-09-30	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M · derivative	Restricted Stock Units	5,000	$0.00	$0	0
2020-09-30	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M	Common Stock	5,000	$0.00	$0	16,414
2020-08-06	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	800	$0.00	$0	0
2020-08-06	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Exercise / conversion M	Common Stock	800	$48.20	$38,560	10,363
2020-06-09	Santelli Jonathan N	EVP, Gen Counsel, Secy	Open-market sell S	Common Stock	1,250	$81.33	$101,664	2,503
2020-06-05	Carson John C Jr.	President	Open-market sell S	Common Stock	10,000	$82.53	$825,271	46,224
2020-06-01	Seshadri Raj	Dir	Exercise / conversion M · derivative	Restricted Stock Units	1,362	$0.00	$0	0
2020-06-01	Seshadri Raj	Dir	Exercise / conversion M	Common Stock	1,362	$0.00	$0	1,362
2020-05-25	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M · derivative	Restricted Stock Units	3,000	$0.00	$0	3,000
2020-05-25	Santelli Jonathan N	EVP, Gen Counsel, Secy	Other disposed transaction F	Common Stock	722	$65.21	$47,082	3,753
2020-05-25	Santelli Jonathan N	EVP, Gen Counsel, Secy	Exercise / conversion M	Common Stock	3,000	$0.00	$0	4,475
2020-05-06	Carson John C Jr.	President	Open-market sell S	Common Stock	8,222	$62.83	$516,549	56,224
2020-05-05	Carson John C Jr.	President	Open-market sell S	Common Stock	6,778	$63.77	$432,264	64,446
2020-03-12	GODBOLD FRANCIS S	Vice Chairman	Open-market buy P	Common Stock	12,500	$61.49	$768,582	159,542
2020-03-11	Allison Paul D	Chair, President & CEO RJ Ltd.	Equity grant / award G	Common Stock	25,500	$0.00	$0	25,500
2020-03-10	REILLY PAUL C	Chairman & CEO	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,500	$0.00	$0	0
2020-03-10	REILLY PAUL C	Chairman & CEO	Other disposed transaction F	Common Stock	1,985	$72.06	$143,039	91,775
2020-03-10	REILLY PAUL C	Chairman & CEO	Exercise / conversion M	Common Stock	2,500	$55.49	$138,725	93,760
2020-03-09	GODBOLD FRANCIS S	Vice Chairman	Open-market buy P	Common Stock	12,542	$65.40	$820,224	147,042
2020-03-04	ACKART JENNIFER C	SVP, Controller & CAO	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	1,741	$0.00	$0	2,259
2020-03-04	ACKART JENNIFER C	SVP, Controller & CAO	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,139	$0.00	$0	2,361
2020-03-04	ACKART JENNIFER C	SVP, Controller & CAO	Other disposed transaction F	Common Stock	2,933	$79.79	$234,024	6,979
2020-03-04	ACKART JENNIFER C	SVP, Controller & CAO	Exercise / conversion M	Common Stock	1,741	$48.20	$83,916	9,912
2020-03-04	ACKART JENNIFER C	SVP, Controller & CAO	Exercise / conversion M	Common Stock	2,139	$55.49	$118,693	8,171
2020-03-03	Curtis Scott A	President, PCG	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	1,866	$0.00	$0	10,634
2020-03-03	Curtis Scott A	President, PCG	Exercise / conversion M	Common Stock	1,866	$55.49	$103,544	83,789
2020-02-20	STORY SUSAN N	Dir	Exercise / conversion M · derivative	Restricted Stock Units	1,789	$0.00	$0	1,481
2020-02-20	STORY SUSAN N	Dir	Equity grant / award A · derivative	Restricted Stock Units	1,481	$0.00	$0	3,270
2020-02-20	STORY SUSAN N	Dir	Exercise / conversion M	Common Stock	1,789	$0.00	$0	26,928
2020-02-19	Johnson Gordon L	Dir	Exercise / conversion M · derivative	Restricted Stock Units	60	$0.00	$0	60
2020-02-19	Johnson Gordon L	Dir	Exercise / conversion M	Common Stock	60	$0.00	$0	18,568
2020-02-17	Johnson Gordon L	Dir	Exercise / conversion M · derivative	Restricted Stock Units	180	$0.00	$0	120
2020-02-17	Johnson Gordon L	Dir	Exercise / conversion M	Common Stock	180	$0.00	$0	18,508
2020-02-05	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	715	$0.00	$0	26,335
2020-02-04	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	300	$0.00	$0	27,050
2020-01-29	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Open-market sell S	Common Stock	5,120	$91.05	$466,176	9,563
2020-01-09	Allaire Bella Loykhter	Executive Vice President-RJA	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,074	$0.00	$0	0
2020-01-09	Allaire Bella Loykhter	Executive Vice President-RJA	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,500	$0.00	$0	0
2020-01-09	Allaire Bella Loykhter	Executive Vice President-RJA	Other disposed transaction F	Common Stock	2,652	$92.85	$246,238	68,835
2020-01-09	Allaire Bella Loykhter	Executive Vice President-RJA	Exercise / conversion M	Common Stock	2,074	$48.20	$99,967	71,487
2020-01-09	Allaire Bella Loykhter	Executive Vice President-RJA	Exercise / conversion M	Common Stock	2,500	$55.49	$138,725	69,413
2020-01-02	REILLY PAUL C	Chairman & CEO	Other disposed transaction F	Common Stock	7,834	$90.78	$711,171	91,260
2019-12-23	TROCIN JEFFREY E	Vice Chairman	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	1,802	$0.00	$0	10,698
2019-12-23	TROCIN JEFFREY E	Vice Chairman	Exercise / conversion M	Common Stock	1,802	$55.49	$99,993	185,890
2019-12-19	REILLY PAUL C	Chairman & CEO	Equity grant / award G	Common Stock	11,779	$0.00	$0	99,094
2019-12-15	Perry Jodi	President, ICD for RJFS	Exercise / conversion M · derivative	Restricted Stock Units	206	$0.00	$0	0
2019-12-15	Perry Jodi	President, ICD for RJFS	Other disposed transaction F	Common Stock	50	$90.88	$4,544	2,126
2019-12-15	Perry Jodi	President, ICD for RJFS	Exercise / conversion M	Common Stock	206	$0.00	$0	2,176
2019-12-15	JAMES THOMAS A	Chairman Emeritus	Exercise / conversion M · derivative	Restricted Stock Units	3,103	$0.00	$0	0
2019-12-15	JAMES THOMAS A	Chairman Emeritus	Exercise / conversion M	Common Stock	3,103	$0.00	$0	12,069,732
2019-12-13	Perry Jodi	President, ICD for RJFS	Equity grant / award A · derivative	Restricted Stock Units	302	$0.00	$0	302
2019-12-13	JAMES THOMAS A	Chairman Emeritus	Equity grant / award A · derivative	Restricted Stock Units	549	$0.00	$0	549
2019-12-12	Perry Jodi	President, ICD for RJFS	Equity grant / award A · derivative	Restricted Stock Units	3,000	$0.00	$0	3,000
2019-12-11	Elwyn Tashtego S	CEO & President - RJA	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	3,134	$0.00	$0	1,802
2019-12-11	Elwyn Tashtego S	CEO & President - RJA	Open-market sell S	Common Stock	3,134	$89.43	$280,276	25,212
2019-12-11	Elwyn Tashtego S	CEO & President - RJA	Exercise / conversion M	Common Stock	3,134	$55.49	$173,906	28,346
2019-12-09	Curtis Scott A	President, PCG	Equity grant / award G	Common Stock	115	$0.00	$0	81,512
2019-12-06	ACKART JENNIFER C	SVP, Controller & CAO	Open-market sell S	Common Stock	2,000	$90.87	$181,744	8,426
2019-12-03	Catanese George	Chief Risk Officer	Equity grant / award G	Common Stock	130	$0.00	$0	5,630
2019-12-03	Catanese George	Chief Risk Officer	Open-market sell S	Common Stock	908	$86.99	$78,987	5,760
2019-12-03	Raney Steven M	President & CEO RJBank	Equity grant / award G	Common Stock	2,238	$0.00	$0	32,967
2019-11-30	Catanese George	Chief Risk Officer	Exercise / conversion M · derivative	Restricted Stock Units	1,200	$0.00	$0	800
2019-11-30	Catanese George	Chief Risk Officer	Other disposed transaction F	Common Stock	292	$89.82	$26,227	6,668
2019-11-30	Catanese George	Chief Risk Officer	Exercise / conversion M	Common Stock	1,200	$0.00	$0	6,960
2019-11-27	Raney Steven M	President & CEO RJBank	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	1,802	$0.00	$0	0
2019-11-27	Raney Steven M	President & CEO RJBank	Exercise / conversion M	Common Stock	1,802	$55.49	$99,993	32,865
2019-11-27	ACKART JENNIFER C	SVP, Controller & CAO	Open-market sell S	Common Stock	3,000	$90.00	$270,000	9,064
2019-11-26	Raney Steven M	President & CEO RJBank	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	698	$0.00	$0	1,802
2019-11-26	Raney Steven M	President & CEO RJBank	Open-market sell S	Common Stock	5,399	$89.05	$480,787	31,063
2019-11-26	Raney Steven M	President & CEO RJBank	Exercise / conversion M	Common Stock	698	$55.49	$38,732	36,462
2019-11-25	GODBOLD FRANCIS S	Vice Chairman	Equity grant / award G	Common Stock	10,000	$0.00	$0	134,500
2019-11-22	Bunn James E	Pres-GlobEq&Inv Banking-RJA	Equity grant / award A · derivative	Restricted Stock Units	5,000	$0.00	$0	5,000
2019-11-21	Carson John C Jr.	President	Open-market sell S	Common Stock	5,000	$89.37	$446,850	62,748
2019-11-21	JAMES THOMAS A	Chairman Emeritus	Equity grant / award A	Common Stock	4,314	$0.00	$0	12,066,629
2019-11-20	Catanese George	Chief Risk Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,320	$0.00	$0	0
2019-11-20	Catanese George	Chief Risk Officer	Exercise / conversion M	Common Stock	2,320	$55.49	$128,737	11,270
2019-11-20	Carson John C Jr.	President	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	5,000	$0.00	$0	0
2019-11-20	Carson John C Jr.	President	Open-market sell S	Common Stock	5,000	$88.31	$441,544	67,748
2019-11-20	Carson John C Jr.	President	Exercise / conversion M	Common Stock	5,000	$55.49	$277,450	72,748
2019-11-19	Catanese George	Chief Risk Officer	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,680	$0.00	$0	2,320
2019-11-19	Catanese George	Chief Risk Officer	Exercise / conversion M	Common Stock	2,680	$55.49	$148,713	8,950
2019-11-19	Perry Jodi	President, ICD for RJFS	Exercise / conversion M · derivative	Restricted Stock Units	200	$0.00	$0	200
2019-11-19	Perry Jodi	President, ICD for RJFS	Other disposed transaction F	Common Stock	48	$89.25	$4,284	1,469
2019-11-19	Perry Jodi	President, ICD for RJFS	Exercise / conversion M	Common Stock	200	$0.00	$0	1,517
2019-11-18	Catanese George	Chief Risk Officer	Exercise / conversion M · derivative	Restricted Stock Units	300	$0.00	$0	300
2019-11-18	Catanese George	Chief Risk Officer	Other disposed transaction F	Common Stock	72	$89.44	$6,440	6,270
2019-11-18	Catanese George	Chief Risk Officer	Exercise / conversion M	Common Stock	300	$0.00	$0	6,342
2019-11-08	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	12,500	$0.00	$0	0
2019-11-08	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Other disposed transaction F	Common Stock	6,363	$89.29	$568,152	40,475
2019-11-08	Dowdle Jeffrey A	COO & Head of Asset Mgmt.	Exercise / conversion M	Common Stock	12,500	$37.87	$473,375	46,838
2019-11-07	Catanese George	Chief Risk Officer	Open-market sell S	Common Stock	464	$89.61	$41,581	6,042
2019-11-05	TROCIN JEFFREY E	Vice Chairman	Open-market sell S	Common Stock	17,360	$88.09	$1,529,268	175,410
2019-11-01	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	175	$0.00	$0	19,898
2019-10-30	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	300	$0.00	$0	20,073
2019-10-29	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	120	$0.00	$0	20,373
2019-10-28	Elwyn Tashtego S	CEO & President - RJA	Equity grant / award G	Common Stock	425	$0.00	$0	20,493
2019-10-04	DUTKOWSKY ROBERT M	Dir	Exercise / conversion M · derivative	Restricted Stock Units	662	$0.00	$0	0
2019-10-04	DUTKOWSKY ROBERT M	Dir	Exercise / conversion M	Common Stock	662	$0.00	$0	662
2019-10-03	Perry Jodi	President, ICD for RJFS	Equity grant / award G	Common Stock	65	$0.00	$0	1,317
2019-09-30	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M · derivative	Restricted Stock Units	5,000	$0.00	$0	0
2019-09-30	Allison Paul D	Chair, President & CEO RJ Ltd.	Exercise / conversion M	Common Stock	5,000	$0.00	$0	29,352
2019-09-12	Dowdle Jeffrey A	CAO & President, Asset Mgmt.	Open-market sell S	Common Stock	8,398	$84.91	$713,080	34,338
2019-09-11	Santelli Jonathan N	EVP, Gen Counsel, Secy	Open-market sell S	Common Stock	1,200	$84.80	$101,756	1,078
2019-08-30	JULIEN JEFFREY P	CFO, Executive VP - Fin	Open-market sell S	Common Stock	15,756	$78.59	$1,238,296	39,592
2019-08-05	TROCIN JEFFREY E	Vice Chairman	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	10,426	$0.00	$0	0
2019-08-05	TROCIN JEFFREY E	Vice Chairman	Exercise / conversion M	Common Stock	10,426	$48.20	$502,533	192,696
2019-08-01	JULIEN JEFFREY P	CFO, Executive VP - Fin	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,500	$0.00	$0	0
2019-08-01	JULIEN JEFFREY P	CFO, Executive VP - Fin	Exercise / conversion M	Common Stock	2,500	$48.20	$120,500	55,348
2018-12-12	Curtis Scott A	Chief Operating Officer	Equity grant / award G	Common Stock	140	$0.00	$0	57,491

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count